faculty_name,faculty_email,publication_type,title,journal,year,doi,url,file_created
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Comparison of total event analysis and first event analysis in relation to heterogeneity in cardiovascular trials.,BMC Medical Research Methodology,2025,10.1186/s12874-025-02593-3,https://experts.mcmaster.ca/display/publication3593638,2025-07-27T15:06:03.593496
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Isolated Glucosuria in Adolescence and Early-Onset Diabetes: A Nationwide Cohort Study of 1.6 Million Adolescents.,Diabetes Care,2025,10.2337/dc24-2402,https://experts.mcmaster.ca/display/publication3552962,2025-07-27T15:06:03.593509
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes.,Diabetes Care,2025,10.2337/dci24-0104,https://experts.mcmaster.ca/display/publication3559942,2025-07-27T15:06:03.593512
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Leveraging Co-Design, Design Thinking, and Service Blueprinting to Create Digital Health Behavior Change Innovations: Insights From a Co-Design Workshop With Type 2 Diabetes Remission Health Coaches.",DST,2025,10.1177/19322968251335303,https://experts.mcmaster.ca/display/publication3576834,2025-07-27T15:06:03.593514
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiometabolic risk factors and disease trends for atrial fibrillation in individuals with type 1 diabetes: a nationwide registry study.,Cardiovascular Diabetology,2025,10.1186/s12933-024-02561-z,https://experts.mcmaster.ca/display/publication3559951,2025-07-27T15:06:03.593515
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight or Obesity.,Diabetes Care,2025,10.2337/dc24-1533,https://experts.mcmaster.ca/display/publication3542865,2025-07-27T15:06:03.593517
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Role of the liver in the sustained normalisation of A1c over 2 years following short-term insulin therapy in early type 2 diabetes.,"Diabetes, Obesity and Metabolism",2025,10.1111/dom.16099,https://experts.mcmaster.ca/display/publication3491954,2025-07-27T15:06:03.593519
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Halving heart failure outcomes by finerenone-mediated type 2 diabetes prevention.,The Lancet Diabetes and Endocrinology,2025,10.1016/S2213-8587(24)00317-6,https://experts.mcmaster.ca/display/publication3529246,2025-07-27T15:06:03.593520
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Overweight and obesity among Israeli adolescents and the risk for serious morbidity in early young adulthood: a nationwide retrospective cohort study.,The Lancet Diabetes and Endocrinology,2025,10.1016/S2213-8587(24)00287-0,https://experts.mcmaster.ca/display/publication3491956,2025-07-27T15:06:03.593522
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.,The Lancet Diabetes and Endocrinology,2025,10.1016/S2213-8587(24)00271-7,https://experts.mcmaster.ca/display/publication3491955,2025-07-27T15:06:03.593523
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Understanding Patient Registries for Diabetes: A Scoping Review of Published Literature.,Journal of Patient Experience,2025,10.1177/23743735251314620,https://experts.mcmaster.ca/display/publication3529245,2025-07-27T15:06:03.593525
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction.,European Heart Journal,2024,10.1093/eurheartj/ehae533,https://experts.mcmaster.ca/display/publication3479940,2025-07-27T15:06:03.593526
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE-O trial.,"Diabetes, Obesity and Metabolism",2024,10.1111/dom.15957,https://experts.mcmaster.ca/display/publication3470457,2025-07-27T15:06:03.593528
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Evaluating remission of type 2 diabetes using a metabolic intervention including fixed-ratio insulin degludec and liraglutide: A randomized controlled trial.,"Diabetes, Obesity and Metabolism",2024,10.1111/dom.15926,https://experts.mcmaster.ca/display/publication3468177,2025-07-27T15:06:03.593529
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"The Effects of Diabetes on Gas Transfer Capacity, Lung Volumes, Muscle Strength, and Cardio-pulmonary Responses During Exercise.",Lung,2024,10.1007/s00408-024-00744-9,https://experts.mcmaster.ca/display/publication3470178,2025-07-27T15:06:03.593531
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.",Circulation,2024,10.1161/CIRCULATIONAHA.124.071689,https://experts.mcmaster.ca/display/publication3468178,2025-07-27T15:06:03.593532
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A Glycemic Threshold Above Which the Improvement of β-Cell Function and Glycemia in Response to Insulin Therapy Is Amplified in Early Type 2 Diabetes: The Reversal of Glucotoxicity.,Diabetes Care,2024,10.2337/dc24-1375,https://experts.mcmaster.ca/display/publication3472257,2025-07-27T15:06:03.593534
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Understanding Patient-Focused Registries for Diabetes: A Scoping Review of Published Literature,Canadian Journal of Diabetes,2024,10.1016/j.jcjd.2024.09.138,https://experts.mcmaster.ca/display/publication3502141,2025-07-27T15:06:03.593536
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Improving analysis of cognitive outcomes in cardiovascular trials using different statistical approaches.,Trials,2024,10.1186/s13063-024-08482-2,https://experts.mcmaster.ca/display/publication3476354,2025-07-27T15:06:03.593537
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial.,Cardiovascular Diabetology,2024,10.1186/s12933-024-02432-7,https://experts.mcmaster.ca/display/publication3476355,2025-07-27T15:06:03.593539
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Relationships between ankle blood pressure indices and major adverse cardiovascular events in people with and without type 2 diabetes.,Cardiovascular Diabetology,2024,10.1186/s12933-024-02383-z,https://experts.mcmaster.ca/display/publication3468179,2025-07-27T15:06:03.593552
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cognitive function in adolescence and the risk of early-onset stroke,Journal of Epidemiology and Community Health,2024,10.1136/jech-2024-222114,https://experts.mcmaster.ca/display/publication3445834,2025-07-27T15:06:03.593554
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Call for effective therapies for preventing dementia in people with type 2 diabetes,The Lancet Diabetes and Endocrinology,2024,10.1016/s2213-8587(24)00158-x,https://experts.mcmaster.ca/display/publication3445827,2025-07-27T15:06:03.593555
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Determinants of serious healthoutcome‐freestatus inmiddle‐agedand older people with dysglycaemia: Exploratory analysis of theORIGINtrial,"Diabetes, Obesity and Metabolism",2024,10.1111/dom.15654,https://experts.mcmaster.ca/display/publication3431200,2025-07-27T15:06:03.593557
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Development and first‐stage validation of a digital version of the Digit Symbol Substitution test for use in assessing cognitive function in older people with diabetes,"Diabetes, Obesity and Metabolism",2024,10.1111/dom.15657,https://experts.mcmaster.ca/display/publication3431199,2025-07-27T15:06:03.593559
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,ASCEND-Eye,"Ophthalmology (Rochester, Minn.)",2024,10.1016/j.ophtha.2024.01.018,https://experts.mcmaster.ca/display/publication3412572,2025-07-27T15:06:03.593561
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,1870-LB: Evaluating Remission of Type 2 Diabetes Using a Metabolic Intervention Including Fixed-Ratio Insulin Degludec and Liraglutide—A Randomized Controlled Trial,Diabetes,2024,10.2337/db24-1870-lb,https://experts.mcmaster.ca/display/publication3445840,2025-07-27T15:06:03.593562
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Arm and ankle blood pressure indices, and peripheral artery disease, and mortality: a cohort study",European Heart Journal,2024,10.1093/eurheartj/ehae087,https://experts.mcmaster.ca/display/publication3402798,2025-07-27T15:06:03.593563
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,ASCEND-Eye,"Ophthalmology (Rochester, Minn.)",2024,10.1016/j.ophtha.2023.11.030,https://experts.mcmaster.ca/display/publication3402228,2025-07-27T15:06:03.593564
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,How clinically relevant is statin-induced diabetes?,The Lancet Diabetes and Endocrinology,2024,10.1016/s2213-8587(24)00059-7,https://experts.mcmaster.ca/display/publication3412457,2025-07-27T15:06:03.593566
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Contemporary Clinical Perspectives on Targeting Remission of Type 2 Diabetes,Journal of Clinical Endocrinology and Metabolism (JCEM),2024,10.1210/clinem/dgad746,https://experts.mcmaster.ca/display/publication3384945,2025-07-27T15:06:03.593567
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiovascular and renal outcomes with varying degrees of kidney disease in high‐risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE‐O trial,"Diabetes, Obesity and Metabolism",2024,10.1111/dom.15417,https://experts.mcmaster.ca/display/publication3324402,2025-07-27T15:06:03.593568
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of theORIGINtrial,"Diabetes, Obesity and Metabolism",2024,10.1111/dom.15412,https://experts.mcmaster.ca/display/publication3387411,2025-07-27T15:06:03.593570
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study,The Lancet Regional Health - Europe,2024,10.1016/j.lanepe.2024.100852,https://experts.mcmaster.ca/display/publication3404842,2025-07-27T15:06:03.593572
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort study,The Lancet Regional Health - Europe,2024,10.1016/j.lanepe.2024.100888,https://experts.mcmaster.ca/display/publication3412573,2025-07-27T15:06:03.593573
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Genetic drivers of heterogeneity in type 2 diabetes pathophysiology,Nature,2024,10.1038/s41586-024-07019-6,https://experts.mcmaster.ca/display/publication3401715,2025-07-27T15:06:03.593575
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Impact of COVID-19 Lockdown on Occurrence of Acute Complications of Type 1 and Type 2 Diabetes and Overall Glycemic Management,Canadian Journal of Diabetes,2024,10.1016/j.jcjd.2023.12.001,https://experts.mcmaster.ca/display/publication3322761,2025-07-27T15:06:03.593576
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100 000 participants",The Lancet Diabetes and Endocrinology,2024,10.1016/s2213-8587(23)00344-3,https://experts.mcmaster.ca/display/publication3393170,2025-07-27T15:06:03.593713
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial,Journal of Diabetes,2024,10.1111/1753-0407.13473,https://experts.mcmaster.ca/display/publication3305715,2025-07-27T15:06:03.593717
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk,Diabetes Care,2024,10.2337/dc23-1488,https://experts.mcmaster.ca/display/publication3321709,2025-07-27T15:06:03.593740
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The association of red and processed meat with gestational diabetes mellitus: Results from 2 Canadian birth cohort studies,PLoS ONE,2024,10.1371/journal.pone.0302208,https://experts.mcmaster.ca/display/publication3436465,2025-07-27T15:06:03.593743
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Visit-to-visit variability in multiple biological measurements and cognitive performance and risk of cardiovascular disease: A cohort study,Cerebral Circulation - Cognition and Behavior,2024,10.1016/j.cccb.2024.100223,https://experts.mcmaster.ca/display/publication3431718,2025-07-27T15:06:03.593767
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial",Scandinavian Cardiovascular Journal,2023,10.1080/14017431.2023.2166101,https://experts.mcmaster.ca/display/publication2835247,2025-07-27T15:06:03.593770
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Cognitive performance following stroke, transient ischaemic attack, myocardial infarction, and hospitalisation: an individual participant data meta-analysis of six randomised controlled trials",The Lancet Healthy Longevity,2023,10.1016/s2666-7568(23)00207-6,https://experts.mcmaster.ca/display/publication3320105,2025-07-27T15:06:03.593771
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Sex hormone-binding globulin and heart failure hospitalizations in patients with dysglycemia,Diabetes Research and Clinical Practice,2023,10.1016/j.diabres.2023.111010,https://experts.mcmaster.ca/display/publication3309079,2025-07-27T15:06:03.593822
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Sex hormone-binding globulin and heart failure hospitalizations in patients with dysglycemia - Experiences from the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial,European Heart Journal,2023,10.1093/eurheartj/ehad655.926,https://experts.mcmaster.ca/display/publication3408838,2025-07-27T15:06:03.593824
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,High BMI and the risk for incident type 1 Diabetes Mellitus: a systematic review and meta-analysis of aggregated cohort studies,Cardiovascular Diabetology,2023,10.1186/s12933-023-02007-y,https://experts.mcmaster.ca/display/publication3305714,2025-07-27T15:06:03.593826
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial","Diabetes, Obesity and Metabolism",2023,10.1111/dom.15234,https://experts.mcmaster.ca/display/publication3283399,2025-07-27T15:06:03.593850
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,IDENTIFICATION OF PAM AS NOVEL MONOGENIC DIABETES GENE,Canadian Journal of Diabetes,2023,10.1016/j.jcjd.2023.10.318,https://experts.mcmaster.ca/display/publication3307083,2025-07-27T15:06:03.593903
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,IDENTIFICATION OF PAM AS NOVEL MONOGENIC DIABETES GENE,Canadian Journal of Cardiology,2023,10.1016/j.cjca.2023.06.315,https://experts.mcmaster.ca/display/publication3302721,2025-07-27T15:06:03.593909
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessment,European Heart Journal Open,2023,10.1093/ehjopen/oead089,https://experts.mcmaster.ca/display/publication3300667,2025-07-27T15:06:03.593911
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus,European Heart Journal - Quality of Care and Clinical Outcomes,2023,10.1093/ehjqcco/qcad030,https://experts.mcmaster.ca/display/publication3235777,2025-07-27T15:06:03.593913
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply,European Heart Journal - Quality of Care and Clinical Outcomes,2023,10.1093/ehjqcco/qcad038,https://experts.mcmaster.ca/display/publication3259131,2025-07-27T15:06:03.593914
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dulaglutide and Kidney Function–Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis,Diabetes Care,2023,10.2337/dc23-0231,https://experts.mcmaster.ca/display/publication3256498,2025-07-27T15:06:03.593916
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetes,Nature Communications,2023,10.1038/s41467-023-40287-w,https://experts.mcmaster.ca/display/publication3274914,2025-07-27T15:06:03.593917
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Diet, cardiovascular disease, and mortality in 80 countries",European Heart Journal,2023,10.1093/eurheartj/ehad269,https://experts.mcmaster.ca/display/publication3258491,2025-07-27T15:06:03.593919
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,GDF15 promotes weight loss by enhancing energy expenditure in muscle,Nature,2023,10.1038/s41586-023-06249-4,https://experts.mcmaster.ca/display/publication3255706,2025-07-27T15:06:03.593920
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Biomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic Risk,JAMA network open,2023,10.1001/jamanetworkopen.2023.25914,https://experts.mcmaster.ca/display/publication3274915,2025-07-27T15:06:03.593922
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Data Monitoring Committee: A Collective or a Collection?,Therapeutic Innovation and Regulatory Science,2023,10.1007/s43441-023-00520-6,https://experts.mcmaster.ca/display/publication3127651,2025-07-27T15:06:03.593923
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,221-LB: Identification of PAM as Novel Monogenic Diabetes Gene,Diabetes,2023,10.2337/db23-221-lb,https://experts.mcmaster.ca/display/publication3257699,2025-07-27T15:06:03.593925
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association of Intima‐Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta‐Analysis of 20 Prospective Studies,Journal of the American Heart Association,2023,10.1161/jaha.122.027657,https://experts.mcmaster.ca/display/publication3250889,2025-07-27T15:06:03.593926
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study,Circulation,2023,10.1161/circulationaha.122.063374,https://experts.mcmaster.ca/display/publication3243163,2025-07-27T15:06:03.593928
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Identifying blood biomarkers for type 2 diabetes subtyping: a report from the ORIGIN trial,Diabetologia,2023,10.1007/s00125-023-05887-7,https://experts.mcmaster.ca/display/publication2894174,2025-07-27T15:06:03.593929
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A culturally tailored personaliseD nutrition intErvention in South ASIan women at risk of Gestational Diabetes Mellitus (DESI-GDM): a randomised controlled trial protocol,BMJ Open,2023,10.1136/bmjopen-2023-072353,https://experts.mcmaster.ca/display/publication3159265,2025-07-27T15:06:03.593930
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis,Diabetes Care,2023,10.2337/dc22-2397,https://experts.mcmaster.ca/display/publication2894204,2025-07-27T15:06:03.593932
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study,The Lancet Diabetes and Endocrinology,2023,10.1016/s2213-8587(23)00062-1,https://experts.mcmaster.ca/display/publication3128144,2025-07-27T15:06:03.593935
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: TheELIXAtrial,"Diabetes, Obesity and Metabolism",2023,10.1111/dom.14954,https://experts.mcmaster.ca/display/publication2632029,2025-07-27T15:06:03.593936
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Patient Perspectives on the Ambulatory Glucose Profile Report for Type 1 Diabetes Management in Adults: A National Online Survey,Canadian Journal of Diabetes,2023,10.1016/j.jcjd.2023.01.001,https://experts.mcmaster.ca/display/publication2951768,2025-07-27T15:06:03.593937
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Thyroid Dysfunction and Cardiovascular Events in Patients With Dysglycemia,Canadian Journal of Diabetes,2023,10.1016/j.jcjd.2023.01.007,https://experts.mcmaster.ca/display/publication2922353,2025-07-27T15:06:03.593939
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial,Circulation,2023,10.1161/circulationaha.122.063716,https://experts.mcmaster.ca/display/publication2922352,2025-07-27T15:06:03.593941
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial,Cardiovascular Diabetology,2023,10.1186/s12933-023-01757-z,https://experts.mcmaster.ca/display/publication2951625,2025-07-27T15:06:03.593943
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers,Diabetes Therapy,2023,10.1007/s13300-022-01353-6,https://experts.mcmaster.ca/display/publication2687625,2025-07-27T15:06:03.593944
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Nailfold capillaroscopy and deep learning in diabetes,Journal of Diabetes,2023,10.1111/1753-0407.13354,https://experts.mcmaster.ca/display/publication2746258,2025-07-27T15:06:03.593946
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,World-wide variations in tests of cognition and activities of daily living in participants of six international randomized controlled trials,Cerebral Circulation - Cognition and Behavior,2023,10.1016/j.cccb.2023.100176,https://experts.mcmaster.ca/display/publication3274453,2025-07-27T15:06:03.593947
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Are U‐shaped relationships between risk factors and outcomes artifactual?,Journal of Diabetes,2022,10.1111/1753-0407.13335,https://experts.mcmaster.ca/display/publication2632030,2025-07-27T15:06:03.593953
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status,The Lancet Diabetes and Endocrinology,2022,10.1016/s2213-8587(22)00313-8,https://experts.mcmaster.ca/display/publication2579798,2025-07-27T15:06:03.593955
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Identifying Blood Biomarkers for Type 2 Diabetes Subtyping: A Report From the ORIGIN Trial,Canadian Journal of Diabetes,2022,10.1016/j.jcjd.2022.09.013,https://experts.mcmaster.ca/display/publication2605787,2025-07-27T15:06:03.593956
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Novel Combination of Continuous Glucose Monitoring Metrics to Predict HbA1c in Type 2 Diabetes,Canadian Journal of Diabetes,2022,10.1016/j.jcjd.2022.09.040,https://experts.mcmaster.ca/display/publication2806420,2025-07-27T15:06:03.593960
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,RF28 | PSUN302 Obesity at Late Adolescence and Incident Type 1 Diabetes in Young Adulthood,Journal of the Endocrine Society,2022,10.1210/jendso/bvac150.893,https://experts.mcmaster.ca/display/publication2688165,2025-07-27T15:06:03.593961
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Reply to the letter regarding the article ‘Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: apost‐hocanalysis from theREWINDrandomized trial’,EUROPEAN JOURNAL OF HEART FAILURE,2022,10.1002/ejhf.2719,https://experts.mcmaster.ca/display/publication2445119,2025-07-27T15:06:03.593963
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin toiGlarLixiin theLixiLan ONE CANrandomized trial,"Diabetes, Obesity and Metabolism",2022,10.1111/dom.14787,https://experts.mcmaster.ca/display/publication2252516,2025-07-27T15:06:03.593964
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dulaglutide and a Composite Outcome Reflecting Atherosclerosis in the REWIND Trial: A Post Hoc Analysis,Diabetes Care,2022,10.2337/dc22-0903,https://experts.mcmaster.ca/display/publication2434477,2025-07-27T15:06:03.593966
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Optimizing Health Coaching for Patients With Type 2 Diabetes Using Machine Learning: Model Development and Validation Study,JMIR Formative Research,2022,10.2196/37838,https://experts.mcmaster.ca/display/publication2430824,2025-07-27T15:06:03.593968
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association of Eligibility for a Sodium-Glucose Cotransporter 2 Inhibitor and Cardiovascular Events in Patients With Atrial Fibrillation,Canadian Journal of Cardiology,2022,10.1016/j.cjca.2022.05.004,https://experts.mcmaster.ca/display/publication2190752,2025-07-27T15:06:03.593969
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Efficacy and safety outcomes of dulaglutide by baselineHbA1c: A post hoc analysis of theREWINDtrial,"Diabetes, Obesity and Metabolism",2022,10.1111/dom.14760,https://experts.mcmaster.ca/display/publication2188567,2025-07-27T15:06:03.593971
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Obesity in late adolescence and incident type 1 diabetes in young adulthood,Diabetologia,2022,10.1007/s00125-022-05722-5,https://experts.mcmaster.ca/display/publication2252518,2025-07-27T15:06:03.593972
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study,Diabetes Care,2022,10.2337/dc22-0453,https://experts.mcmaster.ca/display/publication2378412,2025-07-27T15:06:03.593974
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes",Cardiovascular Diabetology,2022,10.1186/s12933-022-01594-6,https://experts.mcmaster.ca/display/publication2427576,2025-07-27T15:06:03.593975
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study",European Journal of Preventive Cardiology (EJPC),2022,10.1093/eurjpc/zwab209,https://experts.mcmaster.ca/display/publication2188644,2025-07-27T15:06:03.593977
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial,Journal of Clinical Endocrinology and Metabolism (JCEM),2022,10.1210/clinem/dgac200,https://experts.mcmaster.ca/display/publication2188568,2025-07-27T15:06:03.593978
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Response by Lam and Gerstein to Letter Regarding Article, “Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial”",Circulation,2022,10.1161/circulationaha.122.060526,https://experts.mcmaster.ca/display/publication2378411,2025-07-27T15:06:03.593979
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Glucose Intolerance in Pregnancy and Offspring Obesity in Late Adolescence,Diabetes,2022,10.2337/dc21-2634,https://experts.mcmaster.ca/display/publication2379187,2025-07-27T15:06:03.593981
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cushing Syndrome Secondary to Ectopic ACTH Production in Pregnancy: A Case Report,Annals of Internal Medicine: Clinical Cases,2022,10.7326/aimcc.2021.0238,https://experts.mcmaster.ca/display/publication2688166,2025-07-27T15:06:03.593982
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691,Diabetes Care,2022,10.2337/dci22-0013,https://experts.mcmaster.ca/display/publication2252519,2025-07-27T15:06:03.593984
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,1276-P: Transancestral Genomic Analysis Links Dysregulation of Valine Metabolism to the Development of Heart Failure in Type 2 Diabetes,Diabetes,2022,10.2337/db22-1276-p,https://experts.mcmaster.ca/display/publication2273401,2025-07-27T15:06:03.593999
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,190-LB: Vaspin—A Novel Predictor of Type 2 Diabetes Risk,Diabetes,2022,10.2337/db22-190-lb,https://experts.mcmaster.ca/display/publication2273400,2025-07-27T15:06:03.594001
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Biomarkers of Prevalent and Incident Cognitive Dysfunction in People with Dysglycemia: Data from the ORIGIN Trial,Journal of Alzheimer's Disease,2022,10.3233/jad-215195,https://experts.mcmaster.ca/display/publication2253102,2025-07-27T15:06:03.594003
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Shouldn’t Preventing Type 2 Diabetes Also Prevent Its Long-Term Consequences?,Circulation,2022,10.1161/circulationaha.122.060026,https://experts.mcmaster.ca/display/publication2252517,2025-07-27T15:06:03.594005
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Author Correction: Identification of genetic effects underlying type 2 diabetes in South Asian and European populations,Communications Biology,2022,10.1038/s42003-022-03404-x,https://experts.mcmaster.ca/display/publication2189350,2025-07-27T15:06:03.594006
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation,Nature Genetics,2022,10.1038/s41588-022-01058-3,https://experts.mcmaster.ca/display/publication2191844,2025-07-27T15:06:03.594008
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes,Journal of the American Heart Association,2022,10.1161/jaha.121.021327,https://experts.mcmaster.ca/display/publication2186103,2025-07-27T15:06:03.594009
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Identification of genetic effects underlying type 2 diabetes in South Asian and European populations,Communications Biology,2022,10.1038/s42003-022-03248-5,https://experts.mcmaster.ca/display/publication2182759,2025-07-27T15:06:03.594016
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from theREWINDrandomized trial,"Diabetes, Obesity and Metabolism",2022,10.1111/dom.14634,https://experts.mcmaster.ca/display/publication2165450,2025-07-27T15:06:03.594018
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes,Diabetes Care,2022,10.2337/dc21-2196,https://experts.mcmaster.ca/display/publication2176246,2025-07-27T15:06:03.594019
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Consensus report: Definition and interpretation of remission in type 2 diabetes,Diabetologia,2022,10.1111/dme.14669,https://experts.mcmaster.ca/display/publication2122727,2025-07-27T15:06:03.594021
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Economic Analysis of a Diabetes Health Coaching Intervention for Adults Living With Type 2 Diabetes: A Single-Centre Evaluation From a Community-Based Randomized Controlled Trial,Canadian Journal of Diabetes,2022,10.1016/j.jcjd.2021.08.003,https://experts.mcmaster.ca/display/publication2164556,2025-07-27T15:06:03.594022
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial",Diabetes Care,2022,10.2337/dc21-1160,https://experts.mcmaster.ca/display/publication2165449,2025-07-27T15:06:03.594024
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial,Circulation,2022,10.1161/circulationaha.121.057934,https://experts.mcmaster.ca/display/publication2172963,2025-07-27T15:06:03.594025
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Myopia and Early-Onset Type 2 Diabetes: A Nationwide Cohort Study,Journal of Clinical Endocrinology and Metabolism (JCEM),2022,10.1210/clinem/dgab669,https://experts.mcmaster.ca/display/publication2166178,2025-07-27T15:06:03.594027
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial,Diabetes and Metabolic Syndrome: Clinical Research and Reviews,2022,10.1016/j.dsx.2021.102382,https://experts.mcmaster.ca/display/publication2162790,2025-07-27T15:06:03.594030
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes,Journal of Clinical Endocrinology and Metabolism (JCEM),2022,10.1210/clinem/dgab585,https://experts.mcmaster.ca/display/publication2122730,2025-07-27T15:06:03.594031
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial",Diabetes Care,2022,10.2337/dc21-0278,https://experts.mcmaster.ca/display/publication2155015,2025-07-27T15:06:03.594033
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND,Cardiovascular Diabetology,2021,10.1186/s12933-021-01386-4,https://experts.mcmaster.ca/display/publication2129364,2025-07-27T15:06:03.594034
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Insulin Therapy: The Discovery That Shaped a Century,Canadian Journal of Diabetes,2021,10.1016/j.jcjd.2021.03.002,https://experts.mcmaster.ca/display/publication1970394,2025-07-27T15:06:03.594653
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes,New England Journal of Medicine,2021,10.1056/nejmc2115776,https://experts.mcmaster.ca/display/publication2158811,2025-07-27T15:06:03.594673
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Asthma in Youth and Early-onset Type 2 Diabetes: A Nationwide Study of 1.72 Million Israeli Adolescents,Journal of Clinical Endocrinology and Metabolism (JCEM),2021,10.1210/clinem/dgab542,https://experts.mcmaster.ca/display/publication2026344,2025-07-27T15:06:03.594678
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Adolescent cognitive function and incident early-onset type 2 diabetes,EClinicalMedicine,2021,10.1016/j.eclinm.2021.101138,https://experts.mcmaster.ca/display/publication2151511,2025-07-27T15:06:03.594681
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Consensus report: definition and interpretation of remission in type 2 diabetes,Diabetologia,2021,10.1007/s00125-021-05542-z,https://experts.mcmaster.ca/display/publication2122728,2025-07-27T15:06:03.594684
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials",The Lancet Diabetes and Endocrinology,2021,10.1016/s2213-8587(21)00203-5,https://experts.mcmaster.ca/display/publication2127089,2025-07-27T15:06:03.594688
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes,Diabetes Care,2021,10.2337/dci21-0034,https://experts.mcmaster.ca/display/publication2122729,2025-07-27T15:06:03.594691
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Effect of Diabetes Health Coaching on Glycemic Control and Quality of Life in Adults Living With Type 2 Diabetes: A Community-Based, Randomized, Controlled Trial",Canadian Journal of Diabetes,2021,10.1016/j.jcjd.2020.11.012,https://experts.mcmaster.ca/display/publication1959212,2025-07-27T15:06:03.594694
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Lingering Effects of Hyperglycemia in Recently Diagnosed Diabetes During Long-term Follow-up of the DCCT/EDIC and UKPDS Cohorts: More Evidence That Early Control Matters,Diabetes Care,2021,10.2337/dci21-0030,https://experts.mcmaster.ca/display/publication2152374,2025-07-27T15:06:03.594697
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,SODIUM-GLUCOSE CO-TRANSPORTER INHIBITORS AND ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS,Canadian Journal of Cardiology,2021,10.1016/j.cjca.2021.07.094,https://experts.mcmaster.ca/display/publication2140556,2025-07-27T15:06:03.594700
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Sodium‐Glucose Co‐Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials,Journal of the American Heart Association,2021,10.1161/jaha.121.022222,https://experts.mcmaster.ca/display/publication2125223,2025-07-27T15:06:03.594703
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes,New England Journal of Medicine,2021,10.1056/nejmoa2108269,https://experts.mcmaster.ca/display/publication1992563,2025-07-27T15:06:03.594706
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Adolescent Thyroid Disorders and Risk for Type 2 Diabetes in Young Adulthood,Journal of Clinical Endocrinology and Metabolism (JCEM),2021,10.1210/clinem/dgab382,https://experts.mcmaster.ca/display/publication1981345,2025-07-27T15:06:03.594708
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Erectile dysfunction in men with type 2 diabetes treated with dulaglutide: an explanatory analysis of the REWIND placebo-controlled randomised controlled trial (vol 9, pg 484, 2021)",The Lancet Diabetes and Endocrinology,2021,,https://experts.mcmaster.ca/display/publication2065180,2025-07-27T15:06:03.594711
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial,The Lancet Diabetes and Endocrinology,2021,10.1016/s2213-8587(21)00115-7,https://experts.mcmaster.ca/display/publication1984800,2025-07-27T15:06:03.594714
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Short‐term intensive insulin as induction and maintenance therapy for the preservation of beta‐cell function in early type 2 diabetes (RESET‐IT Main): A 2‐year randomized controlled trial,"Diabetes, Obesity and Metabolism",2021,10.1111/dom.14421,https://experts.mcmaster.ca/display/publication1968861,2025-07-27T15:06:03.594717
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin,European Heart Journal,2021,10.1093/eurheartj/ehaa777,https://experts.mcmaster.ca/display/publication1939075,2025-07-27T15:06:03.594730
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia – A brief report from the ORIGIN trial,Journal of Diabetes and its Complications,2021,10.1016/j.jdiacomp.2021.107928,https://experts.mcmaster.ca/display/publication1967691,2025-07-27T15:06:03.594733
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries,JAMA Internal Medicine,2021,10.1001/jamainternmed.2021.0036,https://experts.mcmaster.ca/display/publication1961324,2025-07-27T15:06:03.594736
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Creating Composite Indices From Continuous Variables for Research: The Geometric Mean,Diabetes Care,2021,10.2337/dc20-2446,https://experts.mcmaster.ca/display/publication1960820,2025-07-27T15:06:03.594739
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial,Journal of Clinical Endocrinology and Metabolism (JCEM),2021,10.1210/clinem/dgab065,https://experts.mcmaster.ca/display/publication1958459,2025-07-27T15:06:03.594742
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association Between Bariatric Surgery and Major Adverse Diabetes Outcomes in Patients With Diabetes and Obesity,JAMA network open,2021,10.1001/jamanetworkopen.2021.6820,https://experts.mcmaster.ca/display/publication1967429,2025-07-27T15:06:03.594745
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Stuttering and Incident Type 2 Diabetes: A Population-Based Study of 2.2 Million Adolescents,Journal of Clinical Endocrinology and Metabolism (JCEM),2021,10.1210/clinem/dgaa988,https://experts.mcmaster.ca/display/publication1957251,2025-07-27T15:06:03.594747
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Relationship Between Glucose Control and Cognitive Function in People With Diabetes After a Lacunar Stroke,Journal of Clinical Endocrinology and Metabolism (JCEM),2021,10.1210/clinem/dgab022,https://experts.mcmaster.ca/display/publication1958210,2025-07-27T15:06:03.594750
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trial,Diabetes and Vascular Disease Research,2021,10.1177/14791641211002475,https://experts.mcmaster.ca/display/publication1964787,2025-07-27T15:06:03.594753
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Design and baseline characteristics of theAMPLITUDE‐Ocardiovascular outcomes trial of efpeglenatide, a weekly glucagon‐like peptide‐1 receptor agonist","Diabetes, Obesity and Metabolism",2021,10.1111/dom.14223,https://experts.mcmaster.ca/display/publication1934763,2025-07-27T15:06:03.594756
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Diabetes, Brain Infarcts, Cognition, and Small Vessels in the Canadian Alliance for Healthy Hearts and Minds Study",Journal of Clinical Endocrinology and Metabolism (JCEM),2021,10.1210/clinem/dgaa815,https://experts.mcmaster.ca/display/publication1937487,2025-07-27T15:06:03.594758
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Adolescent Hypertension and Risk for Early-Onset Type 2 Diabetes: A Nationwide Study of 1.9 Million Israeli Adolescents,Diabetes Care,2021,10.2337/dc20-1752,https://experts.mcmaster.ca/display/publication1937489,2025-07-27T15:06:03.594761
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood,Journal of Clinical Endocrinology and Metabolism (JCEM),2021,10.1210/clinem/dgaa753,https://experts.mcmaster.ca/display/publication1936342,2025-07-27T15:06:03.594764
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression,Diabetes Care,2021,10.2337/dc20-1815,https://experts.mcmaster.ca/display/publication1957250,2025-07-27T15:06:03.594766
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Intensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial,Diabetes Care,2021,10.2337/dc20-1842,https://experts.mcmaster.ca/display/publication1937488,2025-07-27T15:06:03.594769
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial,Cardiovascular Diabetology,2020,10.1186/s12933-020-01150-0,https://experts.mcmaster.ca/display/publication1934764,2025-07-27T15:06:03.594772
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study",Diabetes Care,2020,10.2337/dc20-0886,https://experts.mcmaster.ca/display/publication1935246,2025-07-27T15:06:03.594775
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis,Cardiovascular Diabetology,2020,10.1186/s12933-020-01179-1,https://experts.mcmaster.ca/display/publication1939076,2025-07-27T15:06:03.594778
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Abstract 15586: Burden of Cardiovascular or Fatal Outcomes in People With Type 2 Diabetes and Cardiovascular Risk Factors Treated With Dulaglutide a Post Hoc Analysis From the Rewind Trial,Circulation,2020,10.1161/circ.142.suppl_3.15586,https://experts.mcmaster.ca/display/publication2688169,2025-07-27T15:06:03.594781
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The obesity paradigm in cardiovascular disease: the need for differentiated weight management,European Heart Journal,2020,10.1093/eurheartj/ehaa724,https://experts.mcmaster.ca/display/publication1937490,2025-07-27T15:06:03.594784
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of lifelong testosterone exposure on health and disease using Mendelian randomization,eLife,2020,10.7554/elife.58914,https://experts.mcmaster.ca/display/publication1936076,2025-07-27T15:06:03.594787
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"90 - Evaluating the Risk of Malignancy (ROM) in Thyroid Nodules With Bethesda Category III and IV at St. Joseph’s Hospital, Hamilton Compared to the Malignancy Rates Reported in the Bethesda System",Canadian Journal of Diabetes,2020,10.1016/j.jcjd.2020.08.096,https://experts.mcmaster.ca/display/publication2688171,2025-07-27T15:06:03.594790
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Correction to Lancet Neurol 2020; 19: 582–90,Lancet Neurology,2020,10.1016/s1474-4422(20)30303-3,https://experts.mcmaster.ca/display/publication1942846,2025-07-27T15:06:03.594793
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dulaglutide and Kidney Function-Related Outcomes in Type 2 Diabetes: Post Hoc Analysis from the REWIND Trial,Journal of the American Society of Nephrology,2020,10.1681/asn.20203110s1348a,https://experts.mcmaster.ca/display/publication3436667,2025-07-27T15:06:03.594796
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial,Diabetes Care,2020,10.2337/dc19-2046,https://experts.mcmaster.ca/display/publication1917284,2025-07-27T15:06:03.594799
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk,Circulation,2020,10.1161/circulationaha.120.046361,https://experts.mcmaster.ca/display/publication1916015,2025-07-27T15:06:03.594801
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin",Journal of Clinical Endocrinology and Metabolism (JCEM),2020,10.1210/clinem/dgaa248,https://experts.mcmaster.ca/display/publication1895969,2025-07-27T15:06:03.594805
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial,European Heart Journal,2020,10.1093/eurheartj/ehaa293,https://experts.mcmaster.ca/display/publication1895996,2025-07-27T15:06:03.594808
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Adolescent Obesity and Early-Onset Type 2 Diabetes,Diabetes Care,2020,10.2337/dc19-1988,https://experts.mcmaster.ca/display/publication1813280,2025-07-27T15:06:03.594810
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial,Lancet Neurology,2020,10.1016/s1474-4422(20)30173-3,https://experts.mcmaster.ca/display/publication1916017,2025-07-27T15:06:03.594813
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome",EUROPEAN JOURNAL OF HEART FAILURE,2020,10.1002/ejhf.1790,https://experts.mcmaster.ca/display/publication1701935,2025-07-27T15:06:03.594816
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Patient data from routinely collected medical records complement evidence from SGLT2 inhibitor outcome trials,The Lancet Diabetes and Endocrinology,2020,10.1016/s2213-8587(20)30187-x,https://experts.mcmaster.ca/display/publication1916016,2025-07-27T15:06:03.594819
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,MON-636 The Relationship Between Glucose Control & Cognitive Function in People with Diabetes After a Lacunar Stroke,Journal of the Endocrine Society,2020,10.1210/jendso/bvaa046.1737,https://experts.mcmaster.ca/display/publication2688173,2025-07-27T15:06:03.594822
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,OR30-06 Assessment of Dulaglutide Safety in Older Patient Populations in Rewind,Journal of the Endocrine Society,2020,10.1210/jendso/bvaa046.071,https://experts.mcmaster.ca/display/publication2688174,2025-07-27T15:06:03.594825
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Person-Centered, Outcomes-Driven Treatment: A New Paradigm for Type 2 Diabetes in Primary Care",ADA Clinical Compendia,2020,10.2337/db2020-02,https://experts.mcmaster.ca/display/publication2688172,2025-07-27T15:06:03.594827
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,PPARAPolymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid,Diabetes,2020,10.2337/db19-0973,https://experts.mcmaster.ca/display/publication1688731,2025-07-27T15:06:03.594830
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study,Diabetes Care,2020,10.2337/dc19-1973,https://experts.mcmaster.ca/display/publication1689214,2025-07-27T15:06:03.594833
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus,Circulation,2020,10.1161/circulationaha.119.041022,https://experts.mcmaster.ca/display/publication1689144,2025-07-27T15:06:03.594836
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Exploring the Experiences of Adults With Type 2 Diabetes on Sodium Glucose Cotransporter 2 Inhibitors,Canadian Journal of Diabetes,2020,10.1016/j.jcjd.2019.06.004,https://experts.mcmaster.ca/display/publication1663237,2025-07-27T15:06:03.594839
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Are large simple trials for dementia prevention possible?,Age and Ageing,2020,10.1093/ageing/afz152,https://experts.mcmaster.ca/display/publication1683364,2025-07-27T15:06:03.594842
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Accumulation of Deficits as a Key Risk Factor for Cardiovascular Morbidity and Mortality: A Pooled Analysis of 154 000 Individuals,Journal of the American Heart Association,2020,10.1161/jaha.119.014686,https://experts.mcmaster.ca/display/publication1689283,2025-07-27T15:06:03.594845
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dulaglutide slows kidney disease in type 2 diabetes − Author's reply,The Lancet,2020,10.1016/s0140-6736(19)32541-3,https://experts.mcmaster.ca/display/publication1695724,2025-07-27T15:06:03.594847
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Identification of Circulating Proteins Associated With Blood Pressure Using Mendelian Randomization,Circulation. Genomic and precision medicine,2020,10.1161/circgen.119.002605,https://experts.mcmaster.ca/display/publication1688124,2025-07-27T15:06:03.594850
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Novel Biomarkers for Change in Renal Function in People With Dysglycemia,Diabetes Care,2020,10.2337/dc19-1604,https://experts.mcmaster.ca/display/publication1679092,2025-07-27T15:06:03.594853
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial,The Lancet Diabetes and Endocrinology,2020,10.1016/s2213-8587(19)30423-1,https://experts.mcmaster.ca/display/publication1687551,2025-07-27T15:06:03.594856
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Childhood Pancreatitis and Risk for Incident Diabetes in Adulthood,Diabetes Care,2020,10.2337/dc19-1562,https://experts.mcmaster.ca/display/publication1676811,2025-07-27T15:06:03.594859
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss,Nature Metabolism,2019,10.1038/s42255-019-0146-4,https://experts.mcmaster.ca/display/publication1745435,2025-07-27T15:06:03.594862
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"22 - Remission and Regression Following a Short-Term Intensive Metabolic Intervention With Insulin Glargine, Metformin and Dapagliflozin: The REMIT-DAPA Trial",Canadian Journal of Diabetes,2019,10.1016/j.jcjd.2019.07.029,https://experts.mcmaster.ca/display/publication2688176,2025-07-27T15:06:03.594866
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"The Diabetes Health Coaching Randomized Controlled Trial: Rationale, Design and Baseline Characteristics of Adults Living With Type 2 Diabetes",Canadian Journal of Diabetes,2019,10.1016/j.jcjd.2018.10.004,https://experts.mcmaster.ca/display/publication1615295,2025-07-27T15:06:03.594868
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome,Circulation,2019,10.1161/circulationaha.119.040180,https://experts.mcmaster.ca/display/publication1646816,2025-07-27T15:06:03.594871
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Identification of Novel Causal Blood Biomarkers Linking Metabolically Favorable Adiposity With Type 2 Diabetes Risk,Diabetes Care,2019,10.2337/dc18-2444,https://experts.mcmaster.ca/display/publication1646818,2025-07-27T15:06:03.595034
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Generalizability of results from the recent FDA-guided cardiovascular outcomes trials to a representative population with Type 2 Diabetes attending primary care clinics,"Endocrinologia, Diabetes y Nutricion",2019,10.1016/j.endinu.2019.01.005,https://experts.mcmaster.ca/display/publication1634242,2025-07-27T15:06:03.595038
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Generalizability of results from the recent FDA-guided cardiovascular outcomes trials to a representative population with Type 2 Diabetes attending primary care clinics,"Endocrinologia, Diabetes y Nutricion",2019,10.1016/j.endien.2019.08.004,https://experts.mcmaster.ca/display/publication2688175,2025-07-27T15:06:03.595040
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The importance of randomised vs non-randomised trials – Authors' reply,The Lancet,2019,10.1016/s0140-6736(19)31111-0,https://experts.mcmaster.ca/display/publication1663238,2025-07-27T15:06:03.595106
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial",The Lancet,2019,10.1016/s0140-6736(19)31149-3,https://experts.mcmaster.ca/display/publication1645036,2025-07-27T15:06:03.595116
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial",The Lancet,2019,10.1016/s0140-6736(19)31150-x,https://experts.mcmaster.ca/display/publication1645037,2025-07-27T15:06:03.595120
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Cardiovascular Legacy of Good Glycemic Control: Clues About Mediators From the DCCT/EDIC Study,Diabetes Care,2019,10.2337/dci19-0023,https://experts.mcmaster.ca/display/publication1646817,2025-07-27T15:06:03.595124
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic Risk,Trends in Molecular Medicine,2019,10.1016/j.molmed.2019.03.006,https://experts.mcmaster.ca/display/publication1640907,2025-07-27T15:06:03.595127
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Diabetes CareEditors’ Expert Forum 2018: Managing Big Data for Diabetes Research and Care,Diabetes Care,2019,10.2337/dci19-0020,https://experts.mcmaster.ca/display/publication1660354,2025-07-27T15:06:03.595130
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of basal insulin glargine and omega‐3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial,"Diabetes, Obesity and Metabolism",2019,10.1111/dom.13674,https://experts.mcmaster.ca/display/publication1628627,2025-07-27T15:06:03.595133
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States,"Diabetes, Obesity and Metabolism",2019,10.1111/dom.13649,https://experts.mcmaster.ca/display/publication1624600,2025-07-27T15:06:03.595136
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dysglycemia and the Density of the Coronary Vasa Vasorum,Diabetes Care,2019,10.2337/dc18-2483,https://experts.mcmaster.ca/display/publication1634241,2025-07-27T15:06:03.595139
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trial",European Journal of Preventive Cardiology (EJPC),2019,10.1177/2047487318819142,https://experts.mcmaster.ca/display/publication1615294,2025-07-27T15:06:03.595142
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of Disease,Clinical Chemistry,2019,10.1373/clinchem.2018.291104,https://experts.mcmaster.ca/display/publication1603994,2025-07-27T15:06:03.595145
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The association of basal insulin treatment versus standard care with outcomes in anti‐GAD positive and negative subjects: A post‐hoc analysis of the ORIGIN trial,"Diabetes, Obesity and Metabolism",2019,10.1111/dom.13528,https://experts.mcmaster.ca/display/publication1593030,2025-07-27T15:06:03.595148
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Hypoglycemia and Incident Cognitive Dysfunction: A Post Hoc Analysis From the ORIGIN Trial,Diabetes Care,2019,10.2337/dc18-0690,https://experts.mcmaster.ca/display/publication1609489,2025-07-27T15:06:03.595151
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Insulin use for type 2 diabetes: the challenges of predicting trends and modelling care,The Lancet Diabetes and Endocrinology,2019,10.1016/s2213-8587(18)30312-7,https://experts.mcmaster.ca/display/publication1609490,2025-07-27T15:06:03.595154
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Real-world studies no substitute for RCTs in establishing efficacy,The Lancet,2019,10.1016/s0140-6736(18)32840-x,https://experts.mcmaster.ca/display/publication1620985,2025-07-27T15:06:03.595157
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration",Journal of Diabetes Research,2018,10.1155/2018/1631263,https://experts.mcmaster.ca/display/publication1620913,2025-07-27T15:06:03.595160
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cognitive function in adolescence and the risk for premature diabetes and cardiovascular mortality in adulthood,Cardiovascular Diabetology,2018,10.1186/s12933-018-0798-5,https://experts.mcmaster.ca/display/publication1612146,2025-07-27T15:06:03.595162
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Item reduction and validation of the Chinese version of diabetes quality-of-life measure (DQOL),Health and Quality of Life Outcomes,2018,10.1186/s12955-018-0905-z,https://experts.mcmaster.ca/display/publication1513015,2025-07-27T15:06:03.595166
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial,Diabetes Care,2018,10.2337/dc18-0709,https://experts.mcmaster.ca/display/publication1595858,2025-07-27T15:06:03.595168
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Minimally important difference and predictors of change in quality of life in type 2 diabetes: A community‐based survey in China,Diabetes/Metabolism Research and Reviews,2018,10.1002/dmrr.3053,https://experts.mcmaster.ca/display/publication1580555,2025-07-27T15:06:03.595172
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association of preoperative glucose concentration with myocardial injury and death after non-cardiac surgery (GlucoVISION): a prospective cohort study,The Lancet Diabetes and Endocrinology,2018,10.1016/s2213-8587(18)30205-5,https://experts.mcmaster.ca/display/publication1580558,2025-07-27T15:06:03.595175
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study",The Lancet Diabetes and Endocrinology,2018,10.1016/s2213-8587(18)30233-x,https://experts.mcmaster.ca/display/publication1589923,2025-07-27T15:06:03.595178
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Do sulphonylureas still have a place in clinical practice?,The Lancet Diabetes and Endocrinology,2018,10.1016/s2213-8587(18)30025-1,https://experts.mcmaster.ca/display/publication1504833,2025-07-27T15:06:03.595181
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Newly diagnosed type 2 diabetes may serve as a potential marker for pancreatic cancer,Diabetes/Metabolism Research and Reviews,2018,10.1002/dmrr.3018,https://experts.mcmaster.ca/display/publication1521559,2025-07-27T15:06:03.595184
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,P6345Effect of free testosterone levels on cardiovascular outcomes: a Mendelian randomization analysis,European Heart Journal,2018,10.1093/eurheartj/ehy566.p6345,https://experts.mcmaster.ca/display/publication2688177,2025-07-27T15:06:03.595186
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease,Journal of the American College of Cardiology,2018,10.1016/j.jacc.2018.04.067,https://experts.mcmaster.ca/display/publication1570167,2025-07-27T15:06:03.595189
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks,Diabetes Care,2018,10.2337/dci18-0018,https://experts.mcmaster.ca/display/publication1535057,2025-07-27T15:06:03.595192
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"In high-risk T1DM, real-time continuous glucose monitoring vs self-monitoring reduced hypoglycemic events",ACP journal club,2018,10.7326/acpjc-2018-168-10-053,https://experts.mcmaster.ca/display/publication1543929,2025-07-27T15:06:03.595195
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants,American Heart Journal,2018,10.1016/j.ahj.2017.09.001,https://experts.mcmaster.ca/display/publication1535056,2025-07-27T15:06:03.595198
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Genetic Link Between Diabetes and Atherosclerosis,Canadian Journal of Cardiology,2018,10.1016/j.cjca.2018.01.016,https://experts.mcmaster.ca/display/publication1521558,2025-07-27T15:06:03.595201
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Blood HER2 and Uromodulin as Causal Mediators of CKD,Journal of the American Society of Nephrology,2018,10.1681/asn.2017070812,https://experts.mcmaster.ca/display/publication1504182,2025-07-27T15:06:03.595203
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks,JAMA cardiology,2018,10.1001/jamacardio.2017.5205,https://experts.mcmaster.ca/display/publication1494540,2025-07-27T15:06:03.595206
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiovascular Outcomes Trials of Glucose-Lowering Drugs or Strategies in Type 2 Diabetes,Endocrinology and Metabolism Clinics of North America,2018,10.1016/j.ecl.2017.10.003,https://experts.mcmaster.ca/display/publication1496005,2025-07-27T15:06:03.595209
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Insulin resistance and cardiovascular outcomes in theORIGINtrial,"Diabetes, Obesity and Metabolism",2018,10.1111/dom.13112,https://experts.mcmaster.ca/display/publication1456139,2025-07-27T15:06:03.595211
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Determinants of cognitive function in individuals with type 2 diabetes mellitus: A meta-analysis.,Annals of Clinical Psychiatry,2018,10.1177/154733251803000107,https://experts.mcmaster.ca/display/publication1492532,2025-07-27T15:06:03.595214
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD,Diabetes Care,2018,10.2337/dc17-1638,https://experts.mcmaster.ca/display/publication1481249,2025-07-27T15:06:03.595217
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization,Circulation,2018,10.1161/circulationaha.117.030924,https://experts.mcmaster.ca/display/publication1486678,2025-07-27T15:06:03.595220
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From aDiabetes CareEditors’ Expert Forum,Diabetes Care,2018,10.2337/dci17-0057,https://experts.mcmaster.ca/display/publication1486677,2025-07-27T15:06:03.595223
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Design and baseline characteristics of participants in theResearching cardiovascularEvents with aWeeklyINcretin inDiabetes (REWIND) trial on the cardiovascular effects of dulaglutide,"Diabetes, Obesity and Metabolism",2018,10.1111/dom.13028,https://experts.mcmaster.ca/display/publication886213,2025-07-27T15:06:03.595226
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study",American Journal of Medicine,2017,10.1016/j.amjmed.2017.05.047,https://experts.mcmaster.ca/display/publication1446800,2025-07-27T15:06:03.595228
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Maturation of CGM and Glycemic Measurements Beyond HbA1c—A Turning Point in Research and Clinical Decisions,Diabetes Care,2017,10.2337/dci17-0049,https://experts.mcmaster.ca/display/publication1481250,2025-07-27T15:06:03.595231
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Penetrance of Polygenic Obesity Susceptibility Loci across the Body Mass Index Distribution,American Journal of Human Genetics,2017,10.1016/j.ajhg.2017.10.007,https://experts.mcmaster.ca/display/publication1483842,2025-07-27T15:06:03.595234
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus,Journal of the American Heart Association,2017,10.1161/jaha.116.004743,https://experts.mcmaster.ca/display/publication886214,2025-07-27T15:06:03.595237
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial",The Lancet Diabetes and Endocrinology,2017,10.1016/s2213-8587(17)30309-1,https://experts.mcmaster.ca/display/publication1459761,2025-07-27T15:06:03.595240
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus,Circulation,2017,10.1161/circulationaha.117.029503,https://experts.mcmaster.ca/display/publication1467238,2025-07-27T15:06:03.595243
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of insulin glargine on recreational physical activity and TV viewing: Analysis of the randomised ORIGIN trial,Diabetes Research and Clinical Practice,2017,10.1016/j.diabres.2017.07.035,https://experts.mcmaster.ca/display/publication1446801,2025-07-27T15:06:03.595246
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Optimizing the methodology for measuring supraclavicular skin temperature using infrared thermography; implications for measuring brown adipose tissue activity in humans,Scientific Reports,2017,10.1038/s41598-017-11537-x,https://experts.mcmaster.ca/display/publication1459760,2025-07-27T15:06:03.595249
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Relationship Between the Score on a Simple Measure of Cognitive Function and Incident CVD in People With Diabetes: A Post Hoc Epidemiological Analysis From the ACCORD-MIND Study,Journal of Clinical Endocrinology and Metabolism (JCEM),2017,10.1210/jc.2016-3480,https://experts.mcmaster.ca/display/publication886212,2025-07-27T15:06:03.595251
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Causes and consequences of gestational diabetes in South Asians living in Canada: results from a prospective cohort study,CMAJ open,2017,10.9778/cmajo.20170027,https://experts.mcmaster.ca/display/publication1432561,2025-07-27T15:06:03.595254
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Microvascular outcomes in type 2 diabetes – Authors' reply,The Lancet Diabetes and Endocrinology,2017,10.1016/s2213-8587(17)30185-7,https://experts.mcmaster.ca/display/publication1318242,2025-07-27T15:06:03.595257
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Systematic review: Can non-mydriatic cameras accurately detect diabetic retinopathy?,Diabetes Research and Clinical Practice,2017,10.1016/j.diabres.2017.04.024,https://experts.mcmaster.ca/display/publication861711,2025-07-27T15:06:03.595259
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial,Diabetes and Vascular Disease Research,2017,10.1177/1479164117703034,https://experts.mcmaster.ca/display/publication886215,2025-07-27T15:06:03.595263
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Validation of the ORIGIN Cardiovascular Biomarker Panel and the Value of Adding Troponin I in Dysglycemic People,Journal of Clinical Endocrinology and Metabolism (JCEM),2017,10.1210/jc.2017-00273,https://experts.mcmaster.ca/display/publication200846,2025-07-27T15:06:03.595266
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials,The Lancet Diabetes and Endocrinology,2017,10.1016/s2213-8587(17)30104-3,https://experts.mcmaster.ca/display/publication886216,2025-07-27T15:06:03.595269
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Influence of depression on genetic predisposition to type 2 diabetes in a multiethnic longitudinal study,Scientific Reports,2017,10.1038/s41598-017-01406-y,https://experts.mcmaster.ca/display/publication210245,2025-07-27T15:06:03.595272
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial,Journal of Clinical Endocrinology and Metabolism (JCEM),2017,10.1210/jc.2016-3373,https://experts.mcmaster.ca/display/publication751907,2025-07-27T15:06:03.595274
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes,JAMA cardiology,2017,10.1001/jamacardio.2016.4828,https://experts.mcmaster.ca/display/publication886220,2025-07-27T15:06:03.595277
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Growth Differentiation Factor 15 as a Novel Biomarker for Metformin,Diabetes Care,2017,10.2337/dc16-1682,https://experts.mcmaster.ca/display/publication200859,2025-07-27T15:06:03.595280
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From aDiabetes CareEditors’ Expert Forum. Diabetes Care 2016;39:1186–1201,Diabetes Care,2017,10.2337/dci16-0036,https://experts.mcmaster.ca/display/publication886218,2025-07-27T15:06:03.595283
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial,Diabetologia,2017,10.1007/s00125-016-4118-x,https://experts.mcmaster.ca/display/publication886222,2025-07-27T15:06:03.595286
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND),Trials,2016,10.1186/s13063-016-1354-9,https://experts.mcmaster.ca/display/publication1746244,2025-07-27T15:06:03.595289
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Drugs in diabetes in 2016, changes in endocrinology in 2015. Dr. Hertzel Gerstein in an interview with Dr. Roman Jaeschke",Polskie Archiwum Medycyny Wewnetrznej,2016,10.20452/pamw.3663,https://experts.mcmaster.ca/display/publication888688,2025-07-27T15:06:03.595291
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,BMI at Age 17 Years and Diabetes Mortality in Midlife: A Nationwide Cohort of 2.3 Million Adolescents,Diabetes Care,2016,10.2337/dc16-1203,https://experts.mcmaster.ca/display/publication886224,2025-07-27T15:06:03.595294
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial,Diabetes Care,2016,10.2337/dc16-0285,https://experts.mcmaster.ca/display/publication200877,2025-07-27T15:06:03.595297
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes mellitus. Dr. Hertzel Gerstein in an interview with Dr. Roman Jaeschke",Polskie Archiwum Medycyny Wewnetrznej,2016,10.20452/pamw.3612,https://experts.mcmaster.ca/display/publication888690,2025-07-27T15:06:03.595300
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiometabolic Health in Adults Born Premature With Extremely Low Birth Weight,Pediatrics,2016,10.1542/peds.2016-0515,https://experts.mcmaster.ca/display/publication189109,2025-07-27T15:06:03.595302
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Prevalence of Undiagnosed Type 2 Diabetes On The General Medicine Ward,Canadian Journal of Diabetes,2016,10.1016/j.jcjd.2016.08.139,https://experts.mcmaster.ca/display/publication2688190,2025-07-27T15:06:03.595305
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Toward Fairness in Data Sharing,New England Journal of Medicine,2016,10.1056/nejmp1605654,https://experts.mcmaster.ca/display/publication587601,2025-07-27T15:06:03.595308
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Longitudinal relationships between glycemic status and body mass index in a multiethnic study: evidence from observational and genetic epidemiology,Scientific Reports,2016,10.1038/srep30744,https://experts.mcmaster.ca/display/publication208938,2025-07-27T15:06:03.595311
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Making a Difference With Diabetes Research and Care,Diabetes Care,2016,10.2337/dci16-0016,https://experts.mcmaster.ca/display/publication886228,2025-07-27T15:06:03.595313
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Numbers can save lives: Janice Pogue (1962–2016),Clinical Trials,2016,10.1177/1740774516648916,https://experts.mcmaster.ca/display/publication192428,2025-07-27T15:06:03.595316
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study,Diabetes Care,2016,10.2337/dc16-0024,https://experts.mcmaster.ca/display/publication1375849,2025-07-27T15:06:03.595319
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum,Diabetes Care,2016,10.2337/dc16-0873,https://experts.mcmaster.ca/display/publication886226,2025-07-27T15:06:03.595322
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Self-Perceived Emotional Distress and Diabetes Risk Among Young Men,American Journal of Preventive Medicine,2016,10.1016/j.amepre.2015.12.006,https://experts.mcmaster.ca/display/publication886231,2025-07-27T15:06:03.595325
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE),Diabetes Care,2016,10.2337/dc15-1676,https://experts.mcmaster.ca/display/publication310793,2025-07-27T15:06:03.595328
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes,Diabetes Care,2016,10.2337/dc15-2283,https://experts.mcmaster.ca/display/publication1375852,2025-07-27T15:06:03.595340
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Variations in Diabetes Prevalence in Low-, Middle-, and High-Income Countries: Results From the Prospective Urban and Rural Epidemiological Study",Diabetes Care,2016,10.2337/dc15-2338,https://experts.mcmaster.ca/display/publication543165,2025-07-27T15:06:03.595344
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Sleep quality and risk of diabetes and coronary artery disease among young men,Acta Diabetologica,2016,10.1007/s00592-015-0779-z,https://experts.mcmaster.ca/display/publication886243,2025-07-27T15:06:03.595347
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Telomere Length and Risk of Myocardial Infarction in a MultiEthnic Population,Journal of the American College of Cardiology,2016,10.1016/j.jacc.2016.01.061,https://experts.mcmaster.ca/display/publication200891,2025-07-27T15:06:03.595350
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,New Medications for the Treatment of Diabetes,Diabetes Technology and Therapeutics,2016,10.1089/dia.2016.2511,https://experts.mcmaster.ca/display/publication1745544,2025-07-27T15:06:03.595353
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,What accounts for ethnic differences in newborn skinfold thickness comparing South Asians and White Caucasians? Findings from the START and FAMILY Birth Cohorts,International Journal of Obesity,2016,10.1038/ijo.2015.171,https://experts.mcmaster.ca/display/publication183623,2025-07-27T15:06:03.595355
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Physical activity and genetic predisposition to obesity in a multiethnic longitudinal study,Scientific Reports,2016,10.1038/srep18672,https://experts.mcmaster.ca/display/publication208956,2025-07-27T15:06:03.595358
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response,Frontiers in Genetics,2016,10.3389/fgene.2016.00138,https://experts.mcmaster.ca/display/publication1508308,2025-07-27T15:06:03.595360
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Obesity Genes and Risk of Major Depressive Disorder in a Multiethnic Population,Journal of Clinical Psychiatry,2015,10.4088/jcp.14m09720,https://experts.mcmaster.ca/display/publication208987,2025-07-27T15:06:03.595363
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia,Circulation,2015,10.1161/circulationaha.115.015744,https://experts.mcmaster.ca/display/publication200904,2025-07-27T15:06:03.595366
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome,New England Journal of Medicine,2015,10.1056/nejmoa1509225,https://experts.mcmaster.ca/display/publication886233,2025-07-27T15:06:03.595368
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cognitive Performance at Late Adolescence and the Risk for Impaired Fasting Glucose Among Young Adults,Journal of Clinical Endocrinology and Metabolism (JCEM),2015,10.1210/jc.2015-2012,https://experts.mcmaster.ca/display/publication886235,2025-07-27T15:06:03.595371
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074,Diabetes Care,2015,10.2337/dc15-1073,https://experts.mcmaster.ca/display/publication886237,2025-07-27T15:06:03.595374
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Coronary artery disease risk among obese metabolically healthy young men,European Journal of Endocrinology (EJE),2015,10.1530/eje-15-0284,https://experts.mcmaster.ca/display/publication886245,2025-07-27T15:06:03.595377
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dysglycaemia as a cause of cardiovascular outcomes,Nature Reviews Endocrinology,2015,10.1038/nrendo.2015.118,https://experts.mcmaster.ca/display/publication886239,2025-07-27T15:06:03.595387
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Lack of association between type 2 diabetes and major depression: epidemiologic and genetic evidence in a multiethnic population,Translational Psychiatry,2015,10.1038/tp.2015.113,https://experts.mcmaster.ca/display/publication200961,2025-07-27T15:06:03.595390
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Design of FLAT-SUGAR: Randomized Trial of Prandial Insulin Versus Prandial GLP-1 Receptor Agonist Together With Basal Insulin and Metformin for High-Risk Type 2 Diabetes,Diabetes Care,2015,10.2337/dc14-2689,https://experts.mcmaster.ca/display/publication617313,2025-07-27T15:06:03.595393
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Risk Prediction for Early CKD in Type 2 Diabetes,American Society of Nephrology. Clinical Journal,2015,10.2215/cjn.10321014,https://experts.mcmaster.ca/display/publication1463539,2025-07-27T15:06:03.595395
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions,American Journal of Hypertension,2015,10.1093/ajh/hpu292,https://experts.mcmaster.ca/display/publication1463542,2025-07-27T15:06:03.595398
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes,New England Journal of Medicine,2015,10.1056/nejmoa1501352,https://experts.mcmaster.ca/display/publication1508310,2025-07-27T15:06:03.595401
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies,Journal of Clinical Endocrinology and Metabolism (JCEM),2015,10.1210/jc.2015-1367,https://experts.mcmaster.ca/display/publication377556,2025-07-27T15:06:03.595404
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of the dual peroxisome proliferator–activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes,American Heart Journal,2015,10.1016/j.ahj.2015.03.021,https://experts.mcmaster.ca/display/publication886241,2025-07-27T15:06:03.595407
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals,Human Molecular Genetics,2015,10.1093/hmg/ddv097,https://experts.mcmaster.ca/display/publication209061,2025-07-27T15:06:03.595410
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease,European Heart Journal,2015,10.1093/eurheartj/ehv083,https://experts.mcmaster.ca/display/publication200922,2025-07-27T15:06:03.595413
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity",Biochemical Journal,2015,10.1042/bj20150125,https://experts.mcmaster.ca/display/publication762698,2025-07-27T15:06:03.595415
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats,Toxicology and Applied Pharmacology,2015,10.1016/j.taap.2015.03.006,https://experts.mcmaster.ca/display/publication886251,2025-07-27T15:06:03.595418
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort,Diabetes Care,2015,10.2337/dc14-2585,https://experts.mcmaster.ca/display/publication886253,2025-07-27T15:06:03.595421
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo",American Heart Journal,2015,10.1016/j.ahj.2015.02.002,https://experts.mcmaster.ca/display/publication886247,2025-07-27T15:06:03.595424
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus,Kidney International,2015,10.1038/ki.2014.370,https://experts.mcmaster.ca/display/publication910466,2025-07-27T15:06:03.595427
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Obesity Genes and Risk of Major Depression in a Multiethnic Population,Canadian Journal of Diabetes,2015,10.1016/j.jcjd.2015.01.112,https://experts.mcmaster.ca/display/publication2432760,2025-07-27T15:06:03.595430
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of intensive glycaemic control on ischaemic heart disease – Authors' reply,The Lancet,2015,10.1016/s0140-6736(15)60633-x,https://experts.mcmaster.ca/display/publication886249,2025-07-27T15:06:03.595432
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association Between Shortened Leukocyte Telomere Length and Cardiometabolic Outcomes,Circulation. Genomic and precision medicine,2015,10.1161/circgenetics.113.000485,https://experts.mcmaster.ca/display/publication200930,2025-07-27T15:06:03.595436
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Predictors of Nonsevere and Severe Hypoglycemia During Glucose-Lowering Treatment With Insulin Glargine or Standard Drugs in the ORIGIN Trial,Diabetes Care,2015,10.2337/dc14-1329,https://experts.mcmaster.ca/display/publication1463540,2025-07-27T15:06:03.595438
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"The Relationship between Intramuscular Adipose Tissue, Functional Mobility, and Strength in Postmenopausal Women with and without Type 2 Diabetes",Journal of Aging Research,2015,10.1155/2015/872726,https://experts.mcmaster.ca/display/publication874601,2025-07-27T15:06:03.595441
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of Hypoglycemia on Brain Structure in People With Type 2 Diabetes: Epidemiological Analysis of the ACCORD-MIND MRI Trial,Diabetes Care,2014,10.2337/dc14-0973,https://experts.mcmaster.ca/display/publication109823,2025-07-27T15:06:03.595444
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Cross-sectional and Longitudinal Associations of Diabetic Retinopathy With Cognitive Function and Brain MRI Findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial,Diabetes Care,2014,10.2337/dc14-0502,https://experts.mcmaster.ca/display/publication886259,2025-07-27T15:06:03.595447
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cognitive Function and the Risk for Diabetes Among Young Men,Diabetes Care,2014,10.2337/dc14-0715,https://experts.mcmaster.ca/display/publication886263,2025-07-27T15:06:03.595602
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Diabetes Risk Among Overweight and Obese Metabolically Healthy Young Adults,Diabetes Care,2014,10.2337/dc14-0869,https://experts.mcmaster.ca/display/publication886261,2025-07-27T15:06:03.595607
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Does genetic heterogeneity account for the divergent risk of type 2 diabetes in South Asian and white European populations?,Diabetologia,2014,10.1007/s00125-014-3354-1,https://experts.mcmaster.ca/display/publication200935,2025-07-27T15:06:03.595608
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial",The Lancet,2014,10.1016/s0140-6736(14)60611-5,https://experts.mcmaster.ca/display/publication122938,2025-07-27T15:06:03.595610
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial,Diabetologia,2014,10.1007/s00125-014-3318-5,https://experts.mcmaster.ca/display/publication365668,2025-07-27T15:06:03.595642
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored,The Lancet Diabetes and Endocrinology,2014,10.1016/s2213-8587(14)70031-2,https://experts.mcmaster.ca/display/publication886268,2025-07-27T15:06:03.595646
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT)—Results of a Randomized Controlled Pilot Trial,Canadian Journal of Diabetes,2014,10.1016/j.jcjd.2014.07.137,https://experts.mcmaster.ca/display/publication2688181,2025-07-27T15:06:03.595649
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Response to Suissa and Azoulay. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366,Diabetes Care,2014,10.2337/dc14-1220,https://experts.mcmaster.ca/display/publication886257,2025-07-27T15:06:03.595652
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Response to Zanders et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366,Diabetes Care,2014,10.2337/dc14-1567,https://experts.mcmaster.ca/display/publication886255,2025-07-27T15:06:03.595655
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"White blood cell subtypes, insulin resistance and β‐cell dysfunction in high‐risk individuals – the PROMISE cohort",Clinical Endocrinology,2014,10.1111/cen.12390,https://experts.mcmaster.ca/display/publication886273,2025-07-27T15:06:03.595658
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association of cyclooxygenase-2 genetic variant with cardiovascular disease,European Heart Journal,2014,10.1093/eurheartj/ehu168,https://experts.mcmaster.ca/display/publication200941,2025-07-27T15:06:03.595672
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub‐study of theDREAMtrial",Diabetic Medicine,2014,10.1111/dme.12512,https://experts.mcmaster.ca/display/publication201171,2025-07-27T15:06:03.595675
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial,Diabetologia,2014,10.1007/s00125-014-3238-4,https://experts.mcmaster.ca/display/publication886266,2025-07-27T15:06:03.595678
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cost implications of the use of basal insulin glargine in people with early dysglycemia: The ORIGIN trial,Journal of Diabetes and its Complications,2014,10.1016/j.jdiacomp.2014.02.012,https://experts.mcmaster.ca/display/publication457389,2025-07-27T15:06:03.595681
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial,The Lancet Diabetes and Endocrinology,2014,10.1016/s2213-8587(14)70062-2,https://experts.mcmaster.ca/display/publication886265,2025-07-27T15:06:03.595684
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,P3‐091: PLASMA AMYLIN LEVELS ARE ASSOCIATED WITH BRAIN STRUCTURE AMONG INDIVIDUALS WITH TYPE‐2 DIABETES,Alzheimer's and Dementia,2014,10.1016/j.jalz.2014.05.1179,https://experts.mcmaster.ca/display/publication2688179,2025-07-27T15:06:03.595687
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial,American Heart Journal,2014,10.1016/j.ahj.2014.03.021,https://experts.mcmaster.ca/display/publication1463543,2025-07-27T15:06:03.595691
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association of handgrip strength to cardiovascular mortality in pre-diabetic and diabetic patients: A subanalysis of the ORIGIN trial,International Journal of Cardiology,2014,10.1016/j.ijcard.2014.04.013,https://experts.mcmaster.ca/display/publication886267,2025-07-27T15:06:03.595694
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Evaluating the Feasibility and Impact of an Internet-Based Lifestyle Management Program in a Diabetes Care Setting,Diabetes Technology and Therapeutics,2014,10.1089/dia.2013.0278,https://experts.mcmaster.ca/display/publication787360,2025-07-27T15:06:03.596041
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial,Diabetes Care,2014,10.2337/dc13-2334,https://experts.mcmaster.ca/display/publication886270,2025-07-27T15:06:03.596044
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia,Diabetes Care,2014,10.2337/dc13-1468,https://experts.mcmaster.ca/display/publication886271,2025-07-27T15:06:03.596046
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Prospective association of 25(OH)Dwith metabolic syndrome,Clinical Endocrinology,2014,10.1111/cen.12190,https://experts.mcmaster.ca/display/publication886282,2025-07-27T15:06:03.596048
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Variation at the DPP4 locus influences apolipoprotein B levels in South Asians and exhibits heterogeneity in Europeans related to BMI,Diabetologia,2014,10.1007/s00125-013-3142-3,https://experts.mcmaster.ca/display/publication200945,2025-07-27T15:06:03.596050
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cognitive Function and Brain Structure in Persons With Type 2 Diabetes Mellitus After Intensive Lowering of Blood Pressure and Lipid Levels,JAMA Internal Medicine,2014,10.1001/jamainternmed.2013.13656,https://experts.mcmaster.ca/display/publication886272,2025-07-27T15:06:03.596052
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Does a Patient-Managed Insulin Intensification Strategy With Insulin Glargine and Insulin Glulisine Provide Similar Glycemic Control as a Physician-Managed Strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study,Diabetes Care,2014,10.2337/dc13-1636,https://experts.mcmaster.ca/display/publication886275,2025-07-27T15:06:03.596053
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial",Diabetes Care,2014,10.2337/dc13-1545,https://experts.mcmaster.ca/display/publication886274,2025-07-27T15:06:03.596055
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Myocardial Injury after Noncardiac Surgery,Anesthesiology,2014,10.1097/aln.0000000000000113,https://experts.mcmaster.ca/display/publication53045,2025-07-27T15:06:03.596057
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Metabolic effects of telmisartan in subjects with abdominal obesity: A prospective randomized controlled trial,Blood Pressure,2014,10.3109/08037051.2013.791411,https://experts.mcmaster.ca/display/publication210280,2025-07-27T15:06:03.596059
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Willingness to take drugs to prevent serious chronic diseases (自愿服用药物以预防严重的慢性疾病),Journal of Diabetes,2014,10.1111/1753-0407.12069,https://experts.mcmaster.ca/display/publication886281,2025-07-27T15:06:03.596061
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Writing science that your colleagues can read,Journal of Diabetes and its Complications,2014,10.1016/j.jdiacomp.2013.06.009,https://experts.mcmaster.ca/display/publication886278,2025-07-27T15:06:03.596062
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Can community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trial,BMC Health Services Research,2013,10.1186/1472-6963-13-71,https://experts.mcmaster.ca/display/publication886284,2025-07-27T15:06:03.596064
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Changes in trabecular bone microarchitecture in postmenopausal women with and without type 2 diabetes: a two year longitudinal study,BMC Musculoskeletal Disorders,2013,10.1186/1471-2474-14-114,https://experts.mcmaster.ca/display/publication742217,2025-07-27T15:06:03.596065
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Erratum: The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression,Molecular Psychiatry,2013,10.1038/mp.2012.178,https://experts.mcmaster.ca/display/publication1742232,2025-07-27T15:06:03.596067
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression,Molecular Psychiatry,2013,10.1038/mp.2012.160,https://experts.mcmaster.ca/display/publication192738,2025-07-27T15:06:03.596068
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Short Leg Length, a Marker of Early Childhood Deprivation, Is Associated With Metabolic Disorders Underlying Type 2 Diabetes",Diabetes Care,2013,10.2337/dc13-0254,https://experts.mcmaster.ca/display/publication767480,2025-07-27T15:06:03.596070
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial,European Heart Journal,2013,10.1093/eurheartj/eht332,https://experts.mcmaster.ca/display/publication886276,2025-07-27T15:06:03.596071
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association of Depression With Accelerated Cognitive Decline Among Patients With Type 2 Diabetes in the ACCORD-MIND Trial,JAMA psychiatry,2013,10.1001/jamapsychiatry.2013.1965,https://experts.mcmaster.ca/display/publication886277,2025-07-27T15:06:03.596073
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Characteristics Associated With Maintenance of Mean A1C &lt;6.5% in People With Dysglycemia in the ORIGIN Trial,Diabetes Care,2013,10.2337/dc12-2238,https://experts.mcmaster.ca/display/publication1375862,2025-07-27T15:06:03.596083
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Postnatal Metabolic and Reproductive Consequences of Fetal and Neonatal Exposure to the Smoking Cessation Drug Bupropion,Reproductive Sciences,2013,10.1177/1933719113477493,https://experts.mcmaster.ca/display/publication886283,2025-07-27T15:06:03.596085
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Response to Comment on: The ORIGIN Trial Investigators. Characteristics Associated With Maintenance of Mean A1C &lt;6.5% in People With Dysglycemia in the ORIGIN Trial. Diabetes Care 2013;36:2915–2922,Diabetes Care,2013,10.2337/dc13-1319,https://experts.mcmaster.ca/display/publication1463541,2025-07-27T15:06:03.596086
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Dysglycaemia, vasculopenia, and the chronic consequences of diabetes",The Lancet Diabetes and Endocrinology,2013,10.1016/s2213-8587(13)70025-1,https://experts.mcmaster.ca/display/publication886269,2025-07-27T15:06:03.596088
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events,Diabetes Care,2013,10.2337/dc12-2129,https://experts.mcmaster.ca/display/publication848449,2025-07-27T15:06:03.596090
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Genetic Information and the Prediction of Incident Type 2 Diabetes in a High-Risk Multiethnic Population,Diabetes Care,2013,10.2337/dc12-2553,https://experts.mcmaster.ca/display/publication200979,2025-07-27T15:06:03.596097
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Setting the record straight on TIDE: a lost opportunity for patients with diabetes,Diabetologia,2013,10.1007/s00125-013-2959-0,https://experts.mcmaster.ca/display/publication751871,2025-07-27T15:06:03.596099
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Rosiglitazone and Cardiovascular Outcomes,Circulation,2013,10.1161/circulationaha.113.004652,https://experts.mcmaster.ca/display/publication886279,2025-07-27T15:06:03.596101
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of n-3 fatty acids on long-term outcomes of high risk patients with type 2 diabetes mellitus or IGF/IGT with a recent myocardial infarction,European Heart Journal,2013,10.1093/eurheartj/eht308.1966,https://experts.mcmaster.ca/display/publication2434032,2025-07-27T15:06:03.596102
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Determinants of Weight Gain in the Action to Control Cardiovascular Risk in Diabetes Trial,Diabetes Care,2013,10.2337/dc12-1391,https://experts.mcmaster.ca/display/publication886285,2025-07-27T15:06:03.596104
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Do Lifestyle Changes Reduce Serious Outcomes in Diabetes?,New England Journal of Medicine,2013,10.1056/nejme1306987,https://experts.mcmaster.ca/display/publication886280,2025-07-27T15:06:03.596105
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Diabetic Retinopathy, Its Progression, and Incident Cardiovascular Events in the ACCORD Trial",Diabetes Care,2013,10.2337/dc12-1311,https://experts.mcmaster.ca/display/publication886286,2025-07-27T15:06:03.596263
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient mice,Atherosclerosis,2013,10.1016/j.atherosclerosis.2013.01.018,https://experts.mcmaster.ca/display/publication526603,2025-07-27T15:06:03.596265
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dual inhibition of the renin–angiotensin system in high-risk diabetes and risk for stroke and other outcomes,Journal of Hypertension,2013,10.1097/hjh.0b013e32835bf7b0,https://experts.mcmaster.ca/display/publication377841,2025-07-27T15:06:03.596267
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Causal Relationship between Adiponectin and Metabolic Traits: A Mendelian Randomization Study in a Multiethnic Population,PLoS ONE,2013,10.1371/journal.pone.0066808,https://experts.mcmaster.ca/display/publication209013,2025-07-27T15:06:03.596346
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Increased cardiovascular risk after pre‐eclampsia in women with dysglycaemia,Diabetic Medicine,2013,10.1111/dme.12033,https://experts.mcmaster.ca/display/publication201363,2025-07-27T15:06:03.596347
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Impact of a computerized system for evidence-based diabetes care on completeness of records: a before–after study,BMC Medical Informatics and Decision Making,2012,10.1186/1472-6947-12-63,https://experts.mcmaster.ca/display/publication175015,2025-07-27T15:06:03.596349
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Basal Insulin and Cardiovascular and Other Outcomes,New England Journal of Medicine,2012,10.1056/nejmc1210553,https://experts.mcmaster.ca/display/publication1463544,2025-07-27T15:06:03.596351
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Basal insulin and cardiovascular and other outcomes.,New England Journal of Medicine,2012,10.1056/NEJMc1210553,https://experts.mcmaster.ca/display/publication1375819,2025-07-27T15:06:03.596352
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids,Respiratory Medicine,2012,10.1016/j.rmed.2012.07.011,https://experts.mcmaster.ca/display/publication1360860,2025-07-27T15:06:03.596354
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Changes in Alanine Transaminase and Waist to Hip Ratio as Predictors of Regression to Normoglycemia and AUCglucose0-120min in Adult Patients with Prediabetes,Canadian Journal of Diabetes,2012,10.1016/j.jcjd.2012.07.056,https://experts.mcmaster.ca/display/publication2432773,2025-07-27T15:06:03.596356
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Does a Patient-managed (PAT) Insulin Intensification Strategy with Insulin Glargine (iGla) and Insulin Glulisine (iGlu) Provide Similar Glycemic Control as Healthcare Professional-managed (HCP) Strategy? Results of the START Study,Canadian Journal of Diabetes,2012,10.1016/j.jcjd.2012.07.057,https://experts.mcmaster.ca/display/publication2688184,2025-07-27T15:06:03.596357
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,030 Is Accelerated Atherosclerosis a Microvascular Complication of Diabetes?,Canadian Journal of Cardiology,2012,10.1016/j.cjca.2012.07.043,https://experts.mcmaster.ca/display/publication2688086,2025-07-27T15:06:03.596359
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Maternal antioxidants prevent β‐cell apoptosis and promote formation of dual hormone‐expressing endocrine cells in male offspring following fetal and neonatal nicotine exposure,Journal of Diabetes,2012,10.1111/j.1753-0407.2012.00195.x,https://experts.mcmaster.ca/display/publication886291,2025-07-27T15:06:03.596376
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study,European Journal of Preventive Cardiology (EJPC),2012,10.1177/1741826711409327,https://experts.mcmaster.ca/display/publication201503,2025-07-27T15:06:03.596378
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia,New England Journal of Medicine,2012,10.1056/nejmoa1203858,https://experts.mcmaster.ca/display/publication886287,2025-07-27T15:06:03.596379
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia,New England Journal of Medicine,2012,10.1056/nejmoa1203859,https://experts.mcmaster.ca/display/publication886288,2025-07-27T15:06:03.596381
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Error in Viewpoint in: Statin Therapy for Healthy Men Identified as ‘Increased Risk,’",Journal of the American Medical Association (JAMA),2012,10.1001/jama.2012.6832,https://experts.mcmaster.ca/display/publication1740984,2025-07-27T15:06:03.596382
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery,Journal of the American Medical Association (JAMA),2012,10.1001/jama.2012.5502,https://experts.mcmaster.ca/display/publication53156,2025-07-27T15:06:03.596384
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Is regression to normoglycaemia clinically important?,The Lancet,2012,10.1016/s0140-6736(12)60828-9,https://experts.mcmaster.ca/display/publication886289,2025-07-27T15:06:03.596386
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study,International Journal of Clinical Practice,2012,10.1111/j.1742-1241.2012.02894.x,https://experts.mcmaster.ca/display/publication886290,2025-07-27T15:06:03.596387
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Poor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes,Diabetes Care,2012,10.2337/dc11-1855,https://experts.mcmaster.ca/display/publication751901,2025-07-27T15:06:03.596389
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Relationship Between A1C and Fasting Plasma Glucose in Dysglycemia or Type 2 Diabetes,Diabetes Care,2012,10.2337/dc11-1918,https://experts.mcmaster.ca/display/publication886294,2025-07-27T15:06:03.596402
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients,Kidney International,2012,10.1038/ki.2011.415,https://experts.mcmaster.ca/display/publication886298,2025-07-27T15:06:03.596403
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Evaluation of in-stent restenosis in the APPROACH trial (assessment on the prevention of progression by Rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history),International Journal of Cardiovascular Imaging,2012,10.1007/s10554-011-9836-z,https://experts.mcmaster.ca/display/publication1375823,2025-07-27T15:06:03.596405
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study,Cardiovascular Revascularization Medicine,2012,10.1016/j.carrev.2011.12.001,https://experts.mcmaster.ca/display/publication886296,2025-07-27T15:06:03.596407
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials,European Heart Journal,2012,10.1093/eurheartj/ehr400,https://experts.mcmaster.ca/display/publication1375822,2025-07-27T15:06:03.596408
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial",Diabetologia,2012,10.1007/s00125-011-2357-4,https://experts.mcmaster.ca/display/publication751953,2025-07-27T15:06:03.596410
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Glycemic Index Predicts Individual Glucose Responses after Self-Selected Breakfasts in Free-Living, Abdominally Obese Adults",Journal of Nutrition,2012,10.3945/jn.111.146571,https://experts.mcmaster.ca/display/publication210300,2025-07-27T15:06:03.596411
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Piloting a Novel Algorithm for Glucose Control in the Coronary Care Unit,Diabetes Care,2012,10.2337/dc11-0706,https://experts.mcmaster.ca/display/publication886300,2025-07-27T15:06:03.596413
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group,Trials,2011,10.1186/1745-6215-12-48,https://experts.mcmaster.ca/display/publication134476,2025-07-27T15:06:03.596414
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Computerized clinical decision support systems for chronic disease management: A decision-maker-researcher partnership systematic review,Implementation Science,2011,10.1186/1748-5908-6-92,https://experts.mcmaster.ca/display/publication175043,2025-07-27T15:06:03.596416
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Establishing a relationship between prolactin and altered fatty acid β-Oxidation via carnitine palmitoyl transferase 1 in breast cancer cells,BMC Cancer,2011,10.1186/1471-2407-11-56,https://experts.mcmaster.ca/display/publication782759,2025-07-27T15:06:03.596417
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy,Lancet Neurology,2011,10.1016/s1474-4422(11)70188-0,https://experts.mcmaster.ca/display/publication886302,2025-07-27T15:06:03.596419
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Prospective Associations of Vitamin D With β-Cell Function and Glycemia,Diabetes,2011,10.2337/db11-0465,https://experts.mcmaster.ca/display/publication886304,2025-07-27T15:06:03.596420
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Shared Electronic Vascular Risk Decision Support in Primary Care,JAMA Internal Medicine,2011,10.1001/archinternmed.2011.471,https://experts.mcmaster.ca/display/publication441319,2025-07-27T15:06:03.596422
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population,Journal of Diabetes,2011,10.1111/j.1753-0407.2011.00124.x,https://experts.mcmaster.ca/display/publication886306,2025-07-27T15:06:03.596423
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A community-based approach for the self-management of diabetes,International Diabetes Nursing,2011,10.1002/edn.178,https://experts.mcmaster.ca/display/publication1746260,2025-07-27T15:06:03.596425
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of Computer-Generated Tailored Feedback on Glycemic Control in People With Diabetes in the Community,Diabetes Care,2011,10.2337/dc11-0006,https://experts.mcmaster.ca/display/publication175039,2025-07-27T15:06:03.596426
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada",Quality of Life Research,2011,10.1007/s11136-010-9828-9,https://experts.mcmaster.ca/display/publication886312,2025-07-27T15:06:03.596428
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Intensive Glucose Lowering and Cardiovascular Outcomes REPLY,New England Journal of Medicine,2011,,https://experts.mcmaster.ca/display/publication1375821,2025-07-27T15:06:03.596429
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Long-Acting Risperidone and Oral Antipsychotics in Schizophrenia,New England Journal of Medicine,2011,10.1056/nejmc1103917,https://experts.mcmaster.ca/display/publication1463545,2025-07-27T15:06:03.596431
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal,Diabetes Care,2011,10.2337/dc10-1567,https://experts.mcmaster.ca/display/publication212339,2025-07-27T15:06:03.596432
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes,New England Journal of Medicine,2011,10.1056/nejmoa1006524,https://experts.mcmaster.ca/display/publication886308,2025-07-27T15:06:03.596451
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of combining rosiglitazone with either metformin or insulin on β-cell mass and function in an animal model of Type 2 diabetes characterized by reduced β-cell mass at birth,Journal of Diabetes,2011,10.1111/j.1753-0407.2010.00101.x,https://experts.mcmaster.ca/display/publication886318,2025-07-27T15:06:03.596453
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score,European Heart Journal,2011,10.1093/eurheartj/ehq448,https://experts.mcmaster.ca/display/publication210310,2025-07-27T15:06:03.596455
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes,Diabetologia,2011,10.1007/s00125-010-1985-4,https://experts.mcmaster.ca/display/publication886314,2025-07-27T15:06:03.596457
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Dysglycaemia, dyslipidaemia and hypertension: risk factors primarily focused on the disease or risk estimates primarily focused on the patient?",Diabetologia,2011,10.1007/s00125-010-1968-5,https://experts.mcmaster.ca/display/publication886316,2025-07-27T15:06:03.596458
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Serious Cardiovascular Outcomes in Diabetes,Circulation,2011,10.1161/circulationaha.110.948489,https://experts.mcmaster.ca/display/publication886310,2025-07-27T15:06:03.596460
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Adipocyte Hypertrophy, Fatty Liver and Metabolic Risk Factors in South Asians: The Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE)",PLoS ONE,2011,10.1371/journal.pone.0022112,https://experts.mcmaster.ca/display/publication210304,2025-07-27T15:06:03.596461
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association of 25(OH)D and PTH with Metabolic Syndrome and Its Traditional and Nontraditional Components,Journal of Clinical Endocrinology and Metabolism (JCEM),2011,10.1210/jc.2010-1439,https://experts.mcmaster.ca/display/publication886320,2025-07-27T15:06:03.596463
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes (vol 33, pg 1379, 2010)",Diabetes Care,2011,,https://experts.mcmaster.ca/display/publication1375865,2025-07-27T15:06:03.596464
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Errata,Diabetes Care,2011,10.2337/dc11-er01a,https://experts.mcmaster.ca/display/publication1746251,2025-07-27T15:06:03.596466
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Association of Hematological Parameters with Insulin Resistance and beta-Cell Dysfunction in Nondiabetic Subjects (vol 94, pg 3824, 2009)",Journal of Clinical Endocrinology and Metabolism (JCEM),2010,,https://experts.mcmaster.ca/display/publication1521623,2025-07-27T15:06:03.596467
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Association of hematological parameters with insulin resistance and β-cell dysfunction in nondiabetic subjects (Journal of Clinical Endocrinology and Metabolism (2009) 94, (3824-3832))",Journal of Clinical Endocrinology and Metabolism (JCEM),2010,,https://experts.mcmaster.ca/display/publication1746262,2025-07-27T15:06:03.596469
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study",Diabetologia,2010,10.1007/s00125-010-1871-0,https://experts.mcmaster.ca/display/publication192914,2025-07-27T15:06:03.596470
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: Methods of a decision-maker-researcher partnership systematic review,Implementation Science,2010,10.1186/1748-5908-5-12,https://experts.mcmaster.ca/display/publication175078,2025-07-27T15:06:03.596472
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Low-Dose Combination Therapy With Rosiglitazone And Metformin to Prevent Type 2 Diabetes Mellitus (CANOE Trial): A Double-Blind Randomized Controlled Study,Obstetrical and Gynecological Survey,2010,10.1097/ogx.0b013e3182134487,https://experts.mcmaster.ca/display/publication1375864,2025-07-27T15:06:03.596474
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Macular Edema and Thiazolidinediones—Reply,JAMA ophthalmology,2010,10.1001/archophthalmol.2010.288,https://experts.mcmaster.ca/display/publication1375870,2025-07-27T15:06:03.596475
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial,Diabetic Medicine,2010,10.1111/j.1464-5491.2010.03064.x,https://experts.mcmaster.ca/display/publication192901,2025-07-27T15:06:03.596477
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Variation at theNFATC2Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study,Diabetes Care,2010,10.2337/dc10-0452,https://experts.mcmaster.ca/display/publication192921,2025-07-27T15:06:03.596478
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial,The Lancet,2010,10.1016/s0140-6736(10)60576-4,https://experts.mcmaster.ca/display/publication1508307,2025-07-27T15:06:03.596481
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Long-Term Consequences of Fetal and Neonatal Nicotine Exposure: A Critical Review,Toxicological Sciences,2010,10.1093/toxsci/kfq103,https://experts.mcmaster.ca/display/publication886334,2025-07-27T15:06:03.596482
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Effect of Oral Antidiabetic Agents on A1C Levels,Diabetes Care,2010,10.2337/dc09-1727,https://experts.mcmaster.ca/display/publication787358,2025-07-27T15:06:03.596484
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Response to Letter Regarding Article, “Differential Clinical Outcomes Associated With Hypoglycemia and Hyperglycemia in Acute Myocardial Infarction”",Circulation,2010,10.1161/circulationaha.110.951830,https://experts.mcmaster.ca/display/publication1375869,2025-07-27T15:06:03.596486
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes,New England Journal of Medicine,2010,10.1056/nejmoa1001288,https://experts.mcmaster.ca/display/publication886329,2025-07-27T15:06:03.596487
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Anthropometric measures and glucose levels in a large multi-ethnic cohort of individuals at risk of developing type 2 diabetes,Diabetologia,2010,10.1007/s00125-010-1710-3,https://experts.mcmaster.ca/display/publication202495,2025-07-27T15:06:03.596489
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Clinical outcomes trials and the cardiovascular effects of thiazolidinediones: Implications for the evaluation of antidiabetic drugs,American Heart Journal,2010,10.1016/j.ahj.2010.05.019,https://experts.mcmaster.ca/display/publication886327,2025-07-27T15:06:03.596490
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial,Diabetes Care,2010,10.2337/dc10-0125,https://experts.mcmaster.ca/display/publication886339,2025-07-27T15:06:03.596492
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Ethnic Variation in Adiponectin and Leptin Levels and Their Association With Adiposity and Insulin Resistance,Diabetes Care,2010,10.2337/dc09-1392,https://experts.mcmaster.ca/display/publication210319,2025-07-27T15:06:03.596493
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Ethnic Variation in Adiponectin and Leptin Levels and Their Association With Adiposity and Insulin Resistance,Diabetes Care,2010,10.2337/dc09-1392,https://experts.mcmaster.ca/display/publication212328,2025-07-27T15:06:03.596495
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study,The Lancet,2010,10.1016/s0140-6736(10)60746-5,https://experts.mcmaster.ca/display/publication886325,2025-07-27T15:06:03.596496
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs",Diabetes Care,2010,10.2337/dc09-2294,https://experts.mcmaster.ca/display/publication886342,2025-07-27T15:06:03.596498
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?,Value in Health,2010,10.1111/j.1524-4733.2010.00695.x,https://experts.mcmaster.ca/display/publication703868,2025-07-27T15:06:03.596650
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association of Vitamin D With Insulin Resistance and β-Cell Dysfunction in Subjects at Risk for Type 2 Diabetes,Diabetes Care,2010,10.2337/dc09-2321,https://experts.mcmaster.ca/display/publication886340,2025-07-27T15:06:03.596660
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Kidney Disease After Preeclampsia: A Systematic Review and Meta-analysis,American Journal of Kidney Diseases,2010,10.1053/j.ajkd.2009.12.036,https://experts.mcmaster.ca/display/publication206119,2025-07-27T15:06:03.596664
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,More insights on the dysglycaemia–cardiovascular connection,The Lancet,2010,10.1016/s0140-6736(10)60973-7,https://experts.mcmaster.ca/display/publication886323,2025-07-27T15:06:03.596667
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada,Canadian Journal of Cardiology,2010,10.1016/s0828-282x(10)70393-7,https://experts.mcmaster.ca/display/publication886331,2025-07-27T15:06:03.596670
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus (vol 362, pg 1563, 2010)",New England Journal of Medicine,2010,,https://experts.mcmaster.ca/display/publication1375872,2025-07-27T15:06:03.596674
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Metabolic Syndrome and Risk of Acute Myocardial Infarction,Journal of the American College of Cardiology,2010,10.1016/j.jacc.2009.12.053,https://experts.mcmaster.ca/display/publication210318,2025-07-27T15:06:03.596677
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus,New England Journal of Medicine,2010,10.1056/nejmoa1001282,https://experts.mcmaster.ca/display/publication886336,2025-07-27T15:06:03.596679
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus,New England Journal of Medicine,2010,10.1056/nejmoa1001286,https://experts.mcmaster.ca/display/publication886338,2025-07-27T15:06:03.596682
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Rosiglitazone improves pancreatic mitochondrial function in an animal model of dysglycemia: role of the insulin-like growth factor axis,Endocrine,2010,10.1007/s12020-009-9294-8,https://experts.mcmaster.ca/display/publication721558,2025-07-27T15:06:03.596685
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease,Circulation,2010,10.1161/circulationaha.109.881003,https://experts.mcmaster.ca/display/publication886343,2025-07-27T15:06:03.596688
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose,Diabetes Care,2010,10.2337/dc09-1579,https://experts.mcmaster.ca/display/publication886346,2025-07-27T15:06:03.596691
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Lack of Association Between Thiazolidinediones and Macular Edema in Type 2 Diabetes,JAMA ophthalmology,2010,10.1001/archophthalmol.2009.310,https://experts.mcmaster.ca/display/publication886341,2025-07-27T15:06:03.596694
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Does Insulin Therapy Promote, Reduce, or Have a Neutral Effect on Cancers?",Journal of the American Medical Association (JAMA),2010,10.1001/jama.2010.60,https://experts.mcmaster.ca/display/publication886344,2025-07-27T15:06:03.596697
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes",Diabetic Medicine,2010,10.1111/j.1464-5491.2009.02915.x,https://experts.mcmaster.ca/display/publication1463546,2025-07-27T15:06:03.596732
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study",The BMJ,2010,10.1136/bmj.b5444,https://experts.mcmaster.ca/display/publication886345,2025-07-27T15:06:03.596734
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Differential Clinical Outcomes Associated With Hypoglycemia and Hyperglycemia in Acute Myocardial Infarction,Circulation,2009,10.1161/circulationaha.108.837765,https://experts.mcmaster.ca/display/publication886347,2025-07-27T15:06:03.596736
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Intensive glucose control and macrovascular outcomes in type 2 diabetes,Diabetologia,2009,10.1007/s00125-009-1470-0,https://experts.mcmaster.ca/display/publication886349,2025-07-27T15:06:03.596738
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Association of Hematological Parameters with Insulin Resistance and β-Cell Dysfunction in Nondiabetic Subjects,Journal of Clinical Endocrinology and Metabolism (JCEM),2009,10.1210/jc.2009-0719,https://experts.mcmaster.ca/display/publication886350,2025-07-27T15:06:03.596740
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials,Clinical Trials,2009,10.1177/1740774509344440,https://experts.mcmaster.ca/display/publication1508309,2025-07-27T15:06:03.596742
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotine,Endocrine,2009,10.1007/s12020-009-9229-4,https://experts.mcmaster.ca/display/publication625928,2025-07-27T15:06:03.596743
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Albuminuria in chronic heart failure: prevalence and prognostic importance,The Lancet,2009,10.1016/s0140-6736(09)61378-7,https://experts.mcmaster.ca/display/publication886348,2025-07-27T15:06:03.596745
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial,CANADIAN MEDICAL ASSOCIATION JOURNAL,2009,10.1503/cmaj.081272,https://experts.mcmaster.ca/display/publication441360,2025-07-27T15:06:03.596746
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample,Journal of Lipid Research,2009,10.1194/jlr.p900008-jlr200,https://experts.mcmaster.ca/display/publication210329,2025-07-27T15:06:03.596748
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of Ramipril and of Rosiglitazone on Carotid Intima-Media Thickness in People With Impaired Glucose Tolerance or Impaired Fasting Glucose,Journal of the American College of Cardiology,2009,10.1016/j.jacc.2008.12.072,https://experts.mcmaster.ca/display/publication886351,2025-07-27T15:06:03.596749
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Is it possible to reduce cardiovascular risk with glucose-lowering approaches?,Nature Reviews Endocrinology,2009,10.1038/nrendo.2009.49,https://experts.mcmaster.ca/display/publication886353,2025-07-27T15:06:03.596751
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes,Diabetes Care,2009,10.2337/dc09-0125,https://experts.mcmaster.ca/display/publication1375874,2025-07-27T15:06:03.596753
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program,Diabetes Care,2009,10.2337/dc08-1709,https://experts.mcmaster.ca/display/publication886359,2025-07-27T15:06:03.596754
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction,American Heart Journal,2009,10.1016/j.ahj.2008.12.007,https://experts.mcmaster.ca/display/publication886355,2025-07-27T15:06:03.596756
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: Results from the ONTARGET/TRANSCEND Research Programme,Diabetes Research and Clinical Practice,2009,10.1016/j.diabres.2008.12.005,https://experts.mcmaster.ca/display/publication378109,2025-07-27T15:06:03.596758
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dysglycemia and Cardiovascular Risk in the General Population,Circulation,2009,10.1161/circulationaha.108.834408,https://experts.mcmaster.ca/display/publication886357,2025-07-27T15:06:03.596759
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors,Diabetes Care,2009,10.2337/dc08-1153,https://experts.mcmaster.ca/display/publication110131,2025-07-27T15:06:03.596761
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The effect of partial meal replacement therapy on weight loss and glycaemic control in obese individuals with type 2 diabetes,Canadian Journal of Diabetes,2009,10.1016/s1499-2671(09)33216-5,https://experts.mcmaster.ca/display/publication2688191,2025-07-27T15:06:03.596762
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,a meta-analysis of the effect of oral antidiabetic agents on A1c levels at 12 weeks,Canadian Journal of Diabetes,2009,10.1016/s1499-2671(09)33161-5,https://experts.mcmaster.ca/display/publication2688187,2025-07-27T15:06:03.596764
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): Study design and baseline characteristics,American Heart Journal,2008,10.1016/j.ahj.2008.07.025,https://experts.mcmaster.ca/display/publication886361,2025-07-27T15:06:03.596766
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points,Diabetes and Vascular Disease Research,2008,10.3132/dvdr.2008.040,https://experts.mcmaster.ca/display/publication886363,2025-07-27T15:06:03.596767
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dr. Byington and colleagues reply,New England Journal of Medicine,2008,,https://experts.mcmaster.ca/display/publication1746266,2025-07-27T15:06:03.596769
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Intensive glucose control in type 2 diabetes - Reply,New England Journal of Medicine,2008,,https://experts.mcmaster.ca/display/publication1375831,2025-07-27T15:06:03.596770
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Rosiglitazone prevents diabetes by increasing beta‐cell mass in an animal model of type 2 diabetes characterized by reduced beta‐cell mass at birth,"Diabetes, Obesity and Metabolism",2008,10.1111/j.1463-1326.2007.00808.x,https://experts.mcmaster.ca/display/publication625331,2025-07-27T15:06:03.596772
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"The Hemoglobin A1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients With Chronic Heart Failure",JAMA Internal Medicine,2008,10.1001/archinte.168.15.1699,https://experts.mcmaster.ca/display/publication886366,2025-07-27T15:06:03.596773
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dysglycemia and a History of Reproductive Risk Factors,Diabetes Care,2008,10.2337/dc08-0621,https://experts.mcmaster.ca/display/publication206097,2025-07-27T15:06:03.596775
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Relationship of epicardial fat thickness and fasting glucose,International Journal of Cardiology,2008,10.1016/j.ijcard.2007.12.072,https://experts.mcmaster.ca/display/publication886370,2025-07-27T15:06:03.596776
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of Intensive Glucose Lowering in Type 2 Diabetes,New England Journal of Medicine,2008,10.1056/nejmoa0802743,https://experts.mcmaster.ca/display/publication886368,2025-07-27T15:06:03.596778
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Increased Pancreatic Beta-Cell Apoptosis following Fetal and Neonatal Exposure to Nicotine Is Mediated via the Mitochondria,Toxicological Sciences,2008,10.1093/toxsci/kfn012,https://experts.mcmaster.ca/display/publication886374,2025-07-27T15:06:03.596779
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Maternal nicotine exposure increases oxidative stress in the offspring,Free Radical Biology and Medicine,2008,10.1016/j.freeradbiomed.2008.02.010,https://experts.mcmaster.ca/display/publication720958,2025-07-27T15:06:03.596781
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose,Diabetes Care,2008,10.2337/dc07-1868,https://experts.mcmaster.ca/display/publication542873,2025-07-27T15:06:03.596782
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Can family physicians help patients initiate basal insulin therapy successfully?: randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial.,Canadian Family Physician,2008,10.1002/central/cn-00638934,https://experts.mcmaster.ca/display/publication1467277,2025-07-27T15:06:03.596784
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A systematic review of the effect of oral antidiabetic agents on A1C levels.,Canadian Journal of Diabetes,2008,10.1016/s1499-2671(08)24113-4,https://experts.mcmaster.ca/display/publication2688185,2025-07-27T15:06:03.596786
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Assessing the Willingness of Young and Healthy People to take Preventive Medication for Chronic Diseases.,Canadian Journal of Diabetes,2008,10.1016/s1499-2671(08)24087-6,https://experts.mcmaster.ca/display/publication2688188,2025-07-27T15:06:03.596787
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Fetal and Neonatal Nicotine Exposure in Wistar Rats Causes Progressive Pancreatic Mitochondrial Damage and Beta Cell Dysfunction,PLoS ONE,2008,10.1371/journal.pone.0003371,https://experts.mcmaster.ca/display/publication721632,2025-07-27T15:06:03.596789
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Glycemia Management in Family Practice in Canada - Preliminary Results of a Chart Audit from AIM@GP,Canadian Journal of Diabetes,2008,10.1016/s1499-2671(08)24111-0,https://experts.mcmaster.ca/display/publication2688186,2025-07-27T15:06:03.596790
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)",American Heart Journal,2008,10.1016/j.ahj.2007.09.009,https://experts.mcmaster.ca/display/publication910654,2025-07-27T15:06:03.596791
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies,Diabetes Research and Clinical Practice,2007,10.1016/j.diabres.2007.05.004,https://experts.mcmaster.ca/display/publication192213,2025-07-27T15:06:03.596793
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia,Diabetes Research and Clinical Practice,2007,10.1016/j.diabres.2007.05.003,https://experts.mcmaster.ca/display/publication125292,2025-07-27T15:06:03.596794
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Does treatment with rosiglitazone increase cardiovascular risk of patients with type 2 diabetes mellitus?,Nature Reviews Endocrinology,2007,10.1038/ncpendmet0640,https://experts.mcmaster.ca/display/publication886382,2025-07-27T15:06:03.596795
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The effects of exercise training on insulin resistance in patients with coronary artery disease,European Journal of Preventive Cardiology (EJPC),2007,10.1097/hjr.0b013e3282eea540,https://experts.mcmaster.ca/display/publication886376,2025-07-27T15:06:03.596797
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A Family-based Intervention to Promote Healthy Lifestyles in an Aboriginal Community in Canada,Canadian Journal of Public Health,2007,10.1007/bf03405436,https://experts.mcmaster.ca/display/publication210330,2025-07-27T15:06:03.596799
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dysglycemia in a community sample of people treated for schizophrenia: The Diabetes in Schizophrenia in Central-south Ontario (DiSCO) study,Schizophrenia Research,2007,10.1016/j.schres.2007.07.016,https://experts.mcmaster.ca/display/publication751876,2025-07-27T15:06:03.596800
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: The Canadian INSIGHT Study,Diabetes Research and Clinical Practice,2007,10.1016/j.diabres.2007.03.021,https://experts.mcmaster.ca/display/publication339947,2025-07-27T15:06:03.596802
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Abstract 3631: Elevated In-hospital Glucose Level, and not Known History of Diabetes Mellitus, Predicts 30-day Mortality Following Acute ST-elevation Myocardial Infarction",Circulation,2007,10.1161/circ.116.suppl_16.ii_824,https://experts.mcmaster.ca/display/publication2688168,2025-07-27T15:06:03.596803
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Transgenerational effects of fetal and neonatal exposure to nicotine,Endocrine,2007,10.1007/s12020-007-0043-6,https://experts.mcmaster.ca/display/publication886380,2025-07-27T15:06:03.596804
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Fetal and neonatal nicotine exposure and postnatal glucose homeostasis: identifying critical windows of exposure,Journal of Endocrinology,2007,10.1677/joe-07-0050,https://experts.mcmaster.ca/display/publication886392,2025-07-27T15:06:03.596806
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods,American Journal of Cardiology,2007,10.1016/j.amjcard.2007.03.003,https://experts.mcmaster.ca/display/publication886390,2025-07-27T15:06:03.596807
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Glycemia Treatment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial,American Journal of Cardiology,2007,10.1016/j.amjcard.2007.03.004,https://experts.mcmaster.ca/display/publication886388,2025-07-27T15:06:03.596809
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial,American Journal of Cardiology,2007,10.1016/j.amjcard.2007.03.002,https://experts.mcmaster.ca/display/publication886386,2025-07-27T15:06:03.596810
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Point: If it is important to prevent type 2 diabetes, it is important to consider all proven therapies within a comprehensive approach",Journal of Cardiopulmonary Rehabilitation and Prevention,2007,,https://experts.mcmaster.ca/display/publication1375826,2025-07-27T15:06:03.596812
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk,Circulation,2007,10.1161/circulationaha.106.661405,https://experts.mcmaster.ca/display/publication378234,2025-07-27T15:06:03.596813
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events,Diabetes Care,2007,10.2337/dc06-1789,https://experts.mcmaster.ca/display/publication837979,2025-07-27T15:06:03.596815
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of ramipril on the incidence of diabetes - Reply,New England Journal of Medicine,2007,,https://experts.mcmaster.ca/display/publication1389536,2025-07-27T15:06:03.596816
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Point: If It Is Important to Prevent Type 2 Diabetes, It Is Important to Consider All Proven Therapies Within a Comprehensive Approach",Diabetes Care,2007,10.2337/dc06-2147,https://experts.mcmaster.ca/display/publication886394,2025-07-27T15:06:03.596818
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The authors reply [6],New England Journal of Medicine,2007,,https://experts.mcmaster.ca/display/publication1746250,2025-07-27T15:06:03.596819
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus,Circulation,2007,10.1161/circulationaha.106.179294,https://experts.mcmaster.ca/display/publication886395,2025-07-27T15:06:03.596821
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"""I take what I think works for me"": a qualitative study to explore patient perception of diabetes treatment benefits and risks.",Journal of Population Therapeutics and Clinical Pharmacology,2007,,https://experts.mcmaster.ca/display/publication885454,2025-07-27T15:06:03.596822
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Diabetes and cardiovascular disease: explaining the relationship.,Reviews in Cardiovascular Medicine,2007,,https://experts.mcmaster.ca/display/publication751867,2025-07-27T15:06:03.596823
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Erratum,Clinical Chemistry and Laboratory Medicine,2007,10.1515/cclm.2007.510,https://experts.mcmaster.ca/display/publication1746263,2025-07-27T15:06:03.596825
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Low Socioeconomic Status and Increased Risk of Severe Hypoglycemia in Type 1 Diabetes: A Systematic Literature Review,Canadian Journal of Diabetes,2007,10.1016/s1499-2671(07)13010-0,https://experts.mcmaster.ca/display/publication1620861,2025-07-27T15:06:03.596826
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus,Diabetes Care,2007,10.2337/dc07-9917,https://experts.mcmaster.ca/display/publication886396,2025-07-27T15:06:03.596828
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review,Clinical Chemistry and Laboratory Medicine,2007,10.1515/cclm.2007.505,https://experts.mcmaster.ca/display/publication455095,2025-07-27T15:06:03.596829
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Rosiglitazone delays the development of diabetes mellitus (DREAM trial),Cleveland Clinic Journal of Medicine,2007,,https://experts.mcmaster.ca/display/publication1375836,2025-07-27T15:06:03.596837
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes,Diabetes Care,2007,10.2337/dc06-2073x,https://experts.mcmaster.ca/display/publication1375832,2025-07-27T15:06:03.596838
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Reevaluation by High-Performance Liquid Chromatography: Clinical Significance of Microalbuminuria in Individuals at High Risk of Cardiovascular Disease in the Heart Outcomes Prevention Evaluation (HOPE) Study,American Journal of Kidney Diseases,2006,10.1053/j.ajkd.2006.09.003,https://experts.mcmaster.ca/display/publication848470,2025-07-27T15:06:03.596840
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The DREAM trial – Authors' reply,The Lancet,2006,10.1016/s0140-6736(06)69829-2,https://experts.mcmaster.ca/display/publication1375835,2025-07-27T15:06:03.596841
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of Ramipril on the Incidence of Diabetes,New England Journal of Medicine,2006,10.1056/nejmoa065061,https://experts.mcmaster.ca/display/publication886397,2025-07-27T15:06:03.596843
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial,The Lancet,2006,10.1016/s0140-6736(06)69420-8,https://experts.mcmaster.ca/display/publication55102,2025-07-27T15:06:03.596844
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial,"Diabetes, Obesity and Metabolism",2006,10.1111/j.1463-1326.2005.00540.x,https://experts.mcmaster.ca/display/publication1375839,2025-07-27T15:06:03.596846
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial,"Diabetes, Obesity and Metabolism",2006,10.1111/j.1463-1326.2005.00540.x,https://experts.mcmaster.ca/display/publication886398,2025-07-27T15:06:03.596847
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study,Circulation,2006,10.1161/circulationaha.105.590927,https://experts.mcmaster.ca/display/publication128149,2025-07-27T15:06:03.596849
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose‐lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study,Diabetic Medicine,2006,10.1111/j.1464-5491.2006.01881.x,https://experts.mcmaster.ca/display/publication886399,2025-07-27T15:06:03.596850
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Diabetes susceptibility,CANADIAN MEDICAL ASSOCIATION JOURNAL,2006,10.1503/cmaj.1060062,https://experts.mcmaster.ca/display/publication1515003,2025-07-27T15:06:03.596851
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Diabetes susceptibility - Response,CANADIAN MEDICAL ASSOCIATION JOURNAL,2006,10.1503/cmaj.1060062,https://experts.mcmaster.ca/display/publication1375837,2025-07-27T15:06:03.596853
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Intensive insulin therapy reduced cardiovascular disease in type 1 diabetes,ACP journal club,2006,10.7326/acpjc-2006-144-3-063,https://experts.mcmaster.ca/display/publication886400,2025-07-27T15:06:03.596854
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Does pioglitazone prevent macrovascular events in patients with type 2 diabetes?,CANADIAN MEDICAL ASSOCIATION JOURNAL,2006,10.1503/cmaj.060049,https://experts.mcmaster.ca/display/publication886401,2025-07-27T15:06:03.596855
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Reply to comment on: Gerstein HC, Pogue J, Mann JFE et al. (2005) The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 48:1749–1755",Diabetologia,2006,10.1007/s00125-005-0116-0,https://experts.mcmaster.ca/display/publication1375842,2025-07-27T15:06:03.596856
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Why don't pigs get diabetes? Explanations for variations in diabetes susceptibility in human populations living in a diabetogenic environment,CANADIAN MEDICAL ASSOCIATION JOURNAL,2006,10.1503/cmaj.050649,https://experts.mcmaster.ca/display/publication886402,2025-07-27T15:06:03.596858
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies,Diabetologia,2005,10.1007/s00125-005-0023-4,https://experts.mcmaster.ca/display/publication886406,2025-07-27T15:06:03.596859
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes,Diabetologia,2005,10.1007/s00125-005-0022-5,https://experts.mcmaster.ca/display/publication886407,2025-07-27T15:06:03.596860
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis,Diabetologia,2005,10.1007/s00125-005-1858-4,https://experts.mcmaster.ca/display/publication886409,2025-07-27T15:06:03.596862
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.",Evidence report/technology assessment (Summary),2005,,https://experts.mcmaster.ca/display/publication192225,2025-07-27T15:06:03.596863
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure,Circulation,2005,10.1161/circulationaha.104.528166,https://experts.mcmaster.ca/display/publication886411,2025-07-27T15:06:03.596865
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects,Diabetes Care,2005,10.2337/diacare.28.7.1630,https://experts.mcmaster.ca/display/publication886410,2025-07-27T15:06:03.596866
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Insulin Therapy in People Who Have Dysglycemia and Type 2 Diabetes Mellitus: Can It Offer Both Cardiovascular Protection and Beta-Cell Preservation?,Endocrinology and Metabolism Clinics of North America,2005,10.1016/j.ecl.2004.11.002,https://experts.mcmaster.ca/display/publication886413,2025-07-27T15:06:03.596867
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE Study",Clinical Nephrology,2005,10.5414/cnp63181,https://experts.mcmaster.ca/display/publication886412,2025-07-27T15:06:03.596868
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Burden of Treatment Failure in Type 2 Diabetes,Diabetes Care,2005,10.2337/diacare.28.3.761,https://experts.mcmaster.ca/display/publication886414,2025-07-27T15:06:03.596870
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Glycemia and Risk for Cardiovascular Disease,ACP journal club,2005,10.7326/0003-4819-142-3-200502010-00025,https://experts.mcmaster.ca/display/publication1375838,2025-07-27T15:06:03.596871
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Glycemia and Risk for Cardiovascular Disease,ACP journal club,2005,10.7326/0003-4819-142-3-200502010-00024,https://experts.mcmaster.ca/display/publication1467279,2025-07-27T15:06:03.596873
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Individualized electronic decision support and reminders can improve diabetes care in the community.,Proceedings - AMIA . Annual Symposium. AMIA Symposium,2005,,https://experts.mcmaster.ca/display/publication934488,2025-07-27T15:06:03.596874
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The HOPE (Heart Outcomes Prevention Evaluation) Study and its Consequences,Scandinavian Journal of Clinical and Laboratory Investigation,2005,10.1080/00365510500236366,https://experts.mcmaster.ca/display/publication848476,2025-07-27T15:06:03.596876
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease,"Kidney International, Supplement",2004,10.1111/j.1523-1755.2004.09215.x,https://experts.mcmaster.ca/display/publication886417,2025-07-27T15:06:03.596877
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Pre‐prandial vs. post‐prandial capillary glucose measurements as targets for repaglinide dose titration in people with diet‐treated or metformin‐treated Type 2 diabetes: a randomized controlled clinical trial,Diabetic Medicine,2004,10.1111/j.1464-5491.2004.01317.x,https://experts.mcmaster.ca/display/publication886416,2025-07-27T15:06:03.596878
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Effect of Vitamin E Supplementation on Cardiovascular Risk in Diabetic Individuals With Different Haptoglobin Phenotypes,Diabetes Care,2004,10.2337/diacare.27.11.2767,https://experts.mcmaster.ca/display/publication886415,2025-07-27T15:06:03.596880
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Glycosylated Hemoglobin: Finally Ready for Prime Time as a Cardiovascular Risk Factor,ACP journal club,2004,10.7326/0003-4819-141-6-200409210-00014,https://experts.mcmaster.ca/display/publication886418,2025-07-27T15:06:03.596881
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial",Diabetologia,2004,10.1007/s00125-004-1485-5,https://experts.mcmaster.ca/display/publication886419,2025-07-27T15:06:03.596883
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid Cancer,Journal of Clinical Endocrinology and Metabolism (JCEM),2004,10.1210/jc.2003-031167,https://experts.mcmaster.ca/display/publication623897,2025-07-27T15:06:03.596889
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Foot ulcers and amputations in diabetes.,Clinical Evidence,2004,,https://experts.mcmaster.ca/display/publication1514999,2025-07-27T15:06:03.596890
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Patients on Appropriate T4Replacement Are as Content as They Would Be on Any Thyroid Hormone,Journal of Clinical Endocrinology and Metabolism (JCEM),2004,10.1210/jc.2003-032136,https://experts.mcmaster.ca/display/publication1467280,2025-07-27T15:06:03.596892
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: Results of the HOPE Study,Kidney International,2004,10.1111/j.1523-1755.2004.00513.x,https://experts.mcmaster.ca/display/publication886420,2025-07-27T15:06:03.596893
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Authors’ Response: Dosage Recommendations for Combination Regimen of Thyroxine and 3,5,3′-Triiodothyronine",Journal of Clinical Endocrinology and Metabolism (JCEM),2004,10.1210/jc.2003-032072,https://experts.mcmaster.ca/display/publication1375861,2025-07-27T15:06:03.596894
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Dosage Recommendations for Combination Regimen of Thyroxine and 3,5,3′-Triiodothyronine",Journal of Clinical Endocrinology and Metabolism (JCEM),2004,10.1210/jc.2003-031971,https://experts.mcmaster.ca/display/publication1463547,2025-07-27T15:06:03.596895
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Thyroid function screening following radiation therapy for cancers of the head and neck: A survey of Canadian practice patterns,Current Oncology,2004,,https://experts.mcmaster.ca/display/publication1746261,2025-07-27T15:06:03.596897
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Foot ulcers and amputations in diabetes.,Clinical Evidence,2003,,https://experts.mcmaster.ca/display/publication1515000,2025-07-27T15:06:03.596898
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Enalapril reduced the risk for new-onset diabetes in left ventricular dysfunction,ACP journal club,2003,10.7326/acpjc-2003-139-3-068,https://experts.mcmaster.ca/display/publication886422,2025-07-27T15:06:03.596899
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Increased occurrence of diabetes in people with ischemic cardiovascular disease and general and abdominal obesity.,Canadian Journal of Cardiology,2003,,https://experts.mcmaster.ca/display/publication910300,2025-07-27T15:06:03.596901
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: Results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study,American Journal of Kidney Diseases,2003,10.1016/j.ajkd.2003.07.015,https://experts.mcmaster.ca/display/publication1375867,2025-07-27T15:06:03.596902
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study,American Journal of Kidney Diseases,2003,10.1016/j.ajkd.2003.07.015,https://experts.mcmaster.ca/display/publication886423,2025-07-27T15:06:03.596903
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Does a Combination Regimen of Thyroxine (T4) and 3,5,3′-Triiodothyronine Improve Depressive Symptoms Better Than T4Alone in Patients with Hypothyroidism? Results of a Double-Blind, Randomized, Controlled Trial",Journal of Clinical Endocrinology and Metabolism (JCEM),2003,10.1210/jc.2003-030139,https://experts.mcmaster.ca/display/publication886424,2025-07-27T15:06:03.596905
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Reducing publication bias of clinical trials by emphasizing methodological rigour,Canadian Journal of Diabetes,2003,,https://experts.mcmaster.ca/display/publication1746256,2025-07-27T15:06:03.596906
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Relationship of Metabolic Syndrome and Fibrinolytic Dysfunction to Cardiovascular Disease,Circulation,2003,10.1161/01.cir.0000080884.27358.49,https://experts.mcmaster.ca/display/publication210395,2025-07-27T15:06:03.596908
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,New Trial Data on Prevention: Potassium and CV Risk in Hope,PACE - Pacing and Clinical Electrophysiology,2003,10.1046/j.1460-9592.2003.t01-2-00231_2.x,https://experts.mcmaster.ca/display/publication2688180,2025-07-27T15:06:03.596909
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiovascular risk in patients with mild renal insufficiency,"Kidney International, Supplement",2003,10.1046/j.1523-1755.63.s84.27.x,https://experts.mcmaster.ca/display/publication886426,2025-07-27T15:06:03.596911
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Development of Renal Disease in People at High Cardiovascular Risk,Journal of the American Society of Nephrology,2003,10.1097/01.asn.0000051594.21922.99,https://experts.mcmaster.ca/display/publication886427,2025-07-27T15:06:03.596912
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Diagnostic Strategies to Detect Glucose Intolerance in a Multiethnic Population,Diabetes Care,2003,10.2337/diacare.26.2.290,https://experts.mcmaster.ca/display/publication210404,2025-07-27T15:06:03.596914
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A disturbed glucose metabolic state (dysglycaemia) is a key risk factor for cardiovascular events,"European Heart Journal, Supplement",2003,10.1016/s1520-765x(03)90034-4,https://experts.mcmaster.ca/display/publication1375871,2025-07-27T15:06:03.596915
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Acarbose in the treatment of elderly patients with type 2 diabetes,Diabetes Research and Clinical Practice,2003,10.1016/s0168-8227(02)00176-6,https://experts.mcmaster.ca/display/publication1463548,2025-07-27T15:06:03.596917
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Mechanisms of cardiovascular risk reduction with ramipril: insights from HOPE and HOPE substudies,"European Heart Journal, Supplement",2003,10.1016/s1520-765x(03)90063-0,https://experts.mcmaster.ca/display/publication161876,2025-07-27T15:06:03.596918
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"The Relationship Between Dysglycemia and Atherosclerosis in South Asian, Chinese, and European Individuals in Canada",Diabetes Care,2003,10.2337/diacare.26.1.144,https://experts.mcmaster.ca/display/publication193196,2025-07-27T15:06:03.596920
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Foot ulcers and amputations in diabetes.,Clinical Evidence,2002,,https://experts.mcmaster.ca/display/publication1515001,2025-07-27T15:06:03.596921
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes,Diabetes Care,2002,10.2337/diacare.25.11.1919,https://experts.mcmaster.ca/display/publication886428,2025-07-27T15:06:03.596922
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Epidemiologic analyses of risk factors, risk indicators, risk markers, and causal factors",Endocrinology and Metabolism Clinics of North America,2002,10.1016/s0889-8529(02)00019-1,https://experts.mcmaster.ca/display/publication886430,2025-07-27T15:06:03.596924
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE,Diabetes/Metabolism Research and Reviews,2002,10.1002/dmrr.285,https://experts.mcmaster.ca/display/publication886429,2025-07-27T15:06:03.596925
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"The Economic Cost of Diabetes in Canada, 1998",Diabetes Care,2002,10.2337/diacare.25.8.1303,https://experts.mcmaster.ca/display/publication1463549,2025-07-27T15:06:03.596927
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Foot ulcers and amputations in diabetes.,Clinical Evidence,2002,,https://experts.mcmaster.ca/display/publication1515002,2025-07-27T15:06:03.596928
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiovascular Outcomes and Renal Disease,ACP journal club,2002,10.7326/0003-4819-136-8-200204160-00021,https://experts.mcmaster.ca/display/publication1375873,2025-07-27T15:06:03.596929
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiovascular Outcomes and Renal Disease,ACP journal club,2002,10.7326/0003-4819-136-8-200204160-00020,https://experts.mcmaster.ca/display/publication1467278,2025-07-27T15:06:03.596931
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas—a randomized trial,Diabetes Research and Clinical Practice,2002,10.1016/s0168-8227(01)00325-4,https://experts.mcmaster.ca/display/publication836390,2025-07-27T15:06:03.596933
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiovascular Risk in Patients with Early Renal Insufficiency,American Journal of Cardiovascular Drugs,2002,10.2165/00129784-200202030-00003,https://experts.mcmaster.ca/display/publication886421,2025-07-27T15:06:03.596934
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dysglycemia: A Key Cardiovascular Risk Factor,Seminars in Thrombosis and Hemostasis,2002,10.1055/s-2002-32040,https://experts.mcmaster.ca/display/publication886408,2025-07-27T15:06:03.596939
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"The value of large, robust trials: the HOPE study",Practical Diabetes,2002,10.1002/pdi.306,https://experts.mcmaster.ca/display/publication1746253,2025-07-27T15:06:03.596940
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Fasting Versus Postload Glucose Levels,Diabetes Care,2001,10.2337/diacare.24.11.1855,https://experts.mcmaster.ca/display/publication886433,2025-07-27T15:06:03.596942
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Ramipril and the Development of Diabetes,Journal of the American Medical Association (JAMA),2001,10.1001/jama.286.15.1882,https://experts.mcmaster.ca/display/publication910867,2025-07-27T15:06:03.596944
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP)",The Lancet,2001,10.1016/s0140-6736(01)06255-9,https://experts.mcmaster.ca/display/publication210409,2025-07-27T15:06:03.596945
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients,Stroke,2001,10.1161/hs1001.096194,https://experts.mcmaster.ca/display/publication886434,2025-07-27T15:06:03.596947
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial,ACC Cardiosource Review Journal,2001,10.1016/s1062-1458(01)00373-7,https://experts.mcmaster.ca/display/publication2688178,2025-07-27T15:06:03.596948
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals",Journal of the American Medical Association (JAMA),2001,10.1001/jama.286.4.421,https://experts.mcmaster.ca/display/publication886435,2025-07-27T15:06:03.596950
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Fußgeschwüre bei Diabetes,VASA - Journal of Vascular Medicine,2001,10.1024/0301-1526.30.3.233,https://experts.mcmaster.ca/display/publication1472178,2025-07-27T15:06:03.596951
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Reducing the Risk of Cardiovascular Complications in the Long-Term Care Setting,Journal of the American Medical Directors Association,2001,10.1016/s1525-8610(01)80005-0,https://experts.mcmaster.ca/display/publication886425,2025-07-27T15:06:03.596953
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial,ACP journal club,2001,10.7326/0003-4819-134-8-200104170-00007,https://experts.mcmaster.ca/display/publication886436,2025-07-27T15:06:03.596954
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Albuminuria y riesgo de eventos cardiovasculares, mortalidad cardiovascular e insuficiencia cardíaca en sujetos diabéticos y no diabéticos",Hipertension y Riesgo Vascular,2001,10.1016/s1889-1837(01)71208-1,https://experts.mcmaster.ca/display/publication2688189,2025-07-27T15:06:03.596959
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Diabetes and the HOPE study: implications for macrovascular and microvascular disease.,"International Journal of Clinical Practice, Supplement",2001,,https://experts.mcmaster.ca/display/publication886432,2025-07-27T15:06:03.596961
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Diabetic foot ulcers,VASA - Journal of Vascular Medicine,2001,10.1024/0301-1526.30.3.233,https://experts.mcmaster.ca/display/publication1746254,2025-07-27T15:06:03.596962
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Plasma Glucose Level - A Continuous Risk Factor for Vascular Disease in Both Diabetic and Non-Diabetic People,Advances in Experimental Medicine and Biology,2001,10.1007/978-1-4615-1321-6_6,https://experts.mcmaster.ca/display/publication886431,2025-07-27T15:06:03.596964
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,CVD in patients with diabetes,Patient Care,2000,,https://experts.mcmaster.ca/display/publication1746252,2025-07-27T15:06:03.596965
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Miglitol, an α-glucosidase inhibitor, prevents the metformin-induced fall in serum folate and vitamin B12 in subjects with type 2 diabetes",Progress in Food and Nutrition Science,2000,10.1016/s0271-5317(00)80025-1,https://experts.mcmaster.ca/display/publication1365212,2025-07-27T15:06:03.596967
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction,Circulation,2000,10.1161/01.cir.102.9.1014,https://experts.mcmaster.ca/display/publication886437,2025-07-27T15:06:03.596968
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cardiovascular and metabolic benefits of ACE inhibition: moving beyond blood pressure reduction.,Diabetes Care,2000,10.2337/diacare.23.7.882,https://experts.mcmaster.ca/display/publication886438,2025-07-27T15:06:03.596970
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)",The Lancet,2000,10.1016/s0140-6736(00)02502-2,https://experts.mcmaster.ca/display/publication210419,2025-07-27T15:06:03.596971
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators.,Diabetes Care,2000,,https://experts.mcmaster.ca/display/publication886440,2025-07-27T15:06:03.596973
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The HOPE study and diabetes,The Lancet,2000,10.1016/s0140-6736(05)72261-3,https://experts.mcmaster.ca/display/publication1375891,2025-07-27T15:06:03.596975
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The HOPE study and diabetes,The Lancet,2000,10.1016/s0140-6736(00)02076-6,https://experts.mcmaster.ca/display/publication1467273,2025-07-27T15:06:03.596976
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction.,Diabetes Care,2000,10.2337/diacare.23.3.377,https://experts.mcmaster.ca/display/publication886439,2025-07-27T15:06:03.596977
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview,The Lancet,2000,10.1016/s0140-6736(99)08415-9,https://experts.mcmaster.ca/display/publication886442,2025-07-27T15:06:03.596979
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE).",Indian Heart Journal,2000,,https://experts.mcmaster.ca/display/publication210414,2025-07-27T15:06:03.596980
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy,The Lancet,2000,10.1016/s0140-6736(99)12323-7,https://experts.mcmaster.ca/display/publication218415,2025-07-27T15:06:03.596981
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Perceived exertion with glucose ingestion in adolescent males with IDDM,Medicine & Science in Sports & Exercise,2000,10.1097/00005768-200001000-00025,https://experts.mcmaster.ca/display/publication848784,2025-07-27T15:06:03.596983
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Preventing cardiovascular diseases in people with diabetes.,Canadian Journal of Cardiology,1999,,https://experts.mcmaster.ca/display/publication886441,2025-07-27T15:06:03.596984
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A controlled evaluation of a national continuing medical education programme designed to improve family physicians’ implementation of diabetes‐specific clinical practice guidelines,Diabetic Medicine,1999,10.1046/j.1464-5491.1999.00159.x,https://experts.mcmaster.ca/display/publication840990,2025-07-27T15:06:03.596986
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,35th Annual Meeting of the European Association for the Study of Diabetes,Diabetologia,1999,10.1007/bf03375458,https://experts.mcmaster.ca/display/publication82376,2025-07-27T15:06:03.596987
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Review: Glucose levels are associated with cardiovascular risk in persons without diabetes mellitus,Evidence-Based Medicine,1999,,https://experts.mcmaster.ca/display/publication1746258,2025-07-27T15:06:03.596988
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes.,CANADIAN MEDICAL ASSOCIATION JOURNAL,1999,,https://experts.mcmaster.ca/display/publication736457,2025-07-27T15:06:03.596990
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes. Rebuttal to Marshall,CANADIAN MEDICAL ASSOCIATION JOURNAL,1999,,https://experts.mcmaster.ca/display/publication1375883,2025-07-27T15:06:03.596991
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Is glucose a continuous risk factor for cardiovascular mortality?,Diabetes Care,1999,10.2337/diacare.22.5.659,https://experts.mcmaster.ca/display/publication886446,2025-07-27T15:06:03.596993
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis.,Diabetes Care,1999,,https://experts.mcmaster.ca/display/publication886447,2025-07-27T15:06:03.596994
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study,Journal of the American College of Cardiology,1999,10.1016/s0735-1097(98)00637-8,https://experts.mcmaster.ca/display/publication886448,2025-07-27T15:06:03.596996
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,TREATMENT,Evidence-based Cardiovascular Medicine,1999,10.1054/ebcm.1999.0281,https://experts.mcmaster.ca/display/publication2688183,2025-07-27T15:06:03.596997
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent,Canadian Journal of Physiology and Pharmacology,1999,10.1139/y98-146,https://experts.mcmaster.ca/display/publication886444,2025-07-27T15:06:03.596998
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Preventive medicine in a diabetes clinic: an opportunity to make a difference,The Lancet,1999,10.1016/s0140-6736(98)00366-3,https://experts.mcmaster.ca/display/publication886449,2025-07-27T15:06:03.597033
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.",Diabetes Care,1999,10.2337/diacare.22.2.233,https://experts.mcmaster.ca/display/publication886445,2025-07-27T15:06:03.597038
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Antihypertensive therapy in patients with type 2 diabetes mellitus: focus on nephropathy.,Advances in nephrology from the Necker Hospital,1999,,https://experts.mcmaster.ca/display/publication886443,2025-07-27T15:06:03.597040
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Intensive blood glucose control reduced type 2 diabetes mellitus-related end points,ACP journal club,1999,10.7326/acpjc-1999-130-1-002,https://experts.mcmaster.ca/display/publication3408841,2025-07-27T15:06:03.597041
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Metformin reduced diabetes-related end points and all-cause mortality in overweight patients with type 2 diabetes,ACP journal club,1999,10.7326/acpjc-1999-130-1-003,https://experts.mcmaster.ca/display/publication3408840,2025-07-27T15:06:03.597043
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Summary of Randomized Trials of Angiotensin Converting Enzyme Inhibitors,Clinical and Experimental Hypertension,1999,10.3109/10641969909061013,https://experts.mcmaster.ca/display/publication910339,2025-07-27T15:06:03.597044
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene.,Clinical and Investigative Medicine,1998,,https://experts.mcmaster.ca/display/publication883598,2025-07-27T15:06:03.597046
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators.,Canadian Journal of Cardiology,1998,,https://experts.mcmaster.ca/display/publication210428,2025-07-27T15:06:03.597047
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The study of health assessment and risk in ethnic groups (SHARE): Rationale and design,Canadian Journal of Cardiology,1998,,https://experts.mcmaster.ca/display/publication210246,2025-07-27T15:06:03.597049
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group.",Journal of Clinical Endocrinology and Metabolism (JCEM),1998,10.1210/jcem.83.9.5123,https://experts.mcmaster.ca/display/publication1463550,2025-07-27T15:06:03.597051
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dysglycaemia: a cardiovascular risk factor,Diabetes Research and Clinical Practice,1998,10.1016/s0168-8227(98)00036-9,https://experts.mcmaster.ca/display/publication886451,2025-07-27T15:06:03.597052
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Lisinopril inhibited the progression of renal albumin excretion in patients with insulin-dependent diabetes mellitus.,Evidence-based Cardiovascular Medicine,1998,10.1016/s1361-2611(98)80021-3,https://experts.mcmaster.ca/display/publication886403,2025-07-27T15:06:03.597066
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Ramipril slowed the decline in renal function among patients with nephropathy and proteinuria not due to insulin-dependent diabetes mellitus,Evidence-based Cardiovascular Medicine,1998,10.1016/s1361-2611(98)80021-3,https://experts.mcmaster.ca/display/publication886404,2025-07-27T15:06:03.597068
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,1998 clinical practice guidelines for the management of diabetes in Canada,CANADIAN MEDICAL ASSOCIATION JOURNAL,1998,,https://experts.mcmaster.ca/display/publication386769,2025-07-27T15:06:03.597070
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.,CANADIAN MEDICAL ASSOCIATION JOURNAL,1998,,https://experts.mcmaster.ca/display/publication886450,2025-07-27T15:06:03.597071
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Dysglycemia, not just diabetes, is a continuous risk factor for cardiovascular disease",Evidence-based Cardiovascular Medicine,1997,10.1016/s1361-2611(97)80002-4,https://experts.mcmaster.ca/display/publication886405,2025-07-27T15:06:03.597072
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Glucose: a Continuous Risk Factor for Cardiovascular Disease,Diabetic Medicine,1997,10.1002/(sici)1096-9136(199708)14:3+<s25::aid-dia441>3.3.co;2-t,https://experts.mcmaster.ca/display/publication886452,2025-07-27T15:06:03.597074
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature,JAMA Internal Medicine,1997,10.1001/archinte.157.13.1413,https://experts.mcmaster.ca/display/publication886453,2025-07-27T15:06:03.597076
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Psychiatric Symptoms, Bone Density and Non-Specific Symptoms in Patients with Mild Hypercalcemia due to Primary Hyperparathyroidism: A Systematic Overview of the Literature.",Endocrine Journal,1997,10.1507/endocrj.44.367,https://experts.mcmaster.ca/display/publication886454,2025-07-27T15:06:03.597077
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Does treatment withl-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?,Journal of General Internal Medicine,1996,10.1007/bf02598988,https://experts.mcmaster.ca/display/publication190514,2025-07-27T15:06:03.597079
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Insulin infusion followed by multiple daily insulin injections reduced mortality after Ml in diabetes,Evidence-Based Medicine,1996,,https://experts.mcmaster.ca/display/publication1746267,2025-07-27T15:06:03.597080
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Rationale and Design of a Large Study to Evaluate the Renal and Cardiovascular Effects of an ACE Inhibitor and Vitamin E in High-Risk Patients With Diabetes: The MICRO-HOPE Study,Diabetes Care,1996,10.2337/diacare.19.11.1225,https://experts.mcmaster.ca/display/publication412843,2025-07-27T15:06:03.597082
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation.",Diabetes Care,1996,10.2337/diacare.19.11.1225,https://experts.mcmaster.ca/display/publication836420,2025-07-27T15:06:03.597083
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,A New Mutation in the Thyroid Hormone Receptor (TR) β Gene (V458A) in a Family with Resistance to Thyroid Hormone (RTH),Thyroid,1996,10.1089/thy.1996.6.311,https://experts.mcmaster.ca/display/publication886455,2025-07-27T15:06:03.597085
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Risk factors for acute myocardial infarction in Indians: a case-control study,The Lancet,1996,10.1016/s0140-6736(96)02507-x,https://experts.mcmaster.ca/display/publication910957,2025-07-27T15:06:03.597086
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dysglycaemia and risk of cardiovascular disease - Reply,The Lancet,1996,,https://experts.mcmaster.ca/display/publication1375894,2025-07-27T15:06:03.597087
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dysglycaemia and risk of cardiovascular disease,The Lancet,1996,10.1016/s0140-6736(96)91653-0,https://experts.mcmaster.ca/display/publication1467276,2025-07-27T15:06:03.597089
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Dysglycaemia and risk of cardiovascular disease,The Lancet,1996,10.1016/s0140-6736(96)91420-8,https://experts.mcmaster.ca/display/publication886456,2025-07-27T15:06:03.597090
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Users' Guides to the Medical Literature,Journal of the American Medical Association (JAMA),1996,10.1001/jama.1996.03530310060034,https://experts.mcmaster.ca/display/publication2688182,2025-07-27T15:06:03.597092
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.",Canadian Journal of Cardiology,1996,,https://experts.mcmaster.ca/display/publication393084,2025-07-27T15:06:03.597093
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Insulin infusion followed by multiple daily insulin injections reduced mortality after MI in diabetes,ACP journal club,1996,10.7326/acpjc-1996-124-1-001,https://experts.mcmaster.ca/display/publication3408842,2025-07-27T15:06:03.597095
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The Relationship Between Cow’s Milk Exposure and Type 1 Diabetes,Diabetic Medicine,1996,10.1002/(sici)1096-9136(199601)13:1<23::aid-dia4>3.0.co;2-d,https://experts.mcmaster.ca/display/publication886457,2025-07-27T15:06:03.597096
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,USERS GUIDES TO THE MEDICAL LITERATURE .9. A METHOD FOR GRADING HEALTH-CARE RECOMMENDATIONS,Journal of the American Medical Association (JAMA),1995,10.1001/jama.274.22.1800,https://experts.mcmaster.ca/display/publication218355,2025-07-27T15:06:03.597097
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group,Journal of the American Medical Association (JAMA),1995,10.1001/jama.274.22.1800,https://experts.mcmaster.ca/display/publication212042,2025-07-27T15:06:03.597099
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Collaborative cardiovascular clinical trials in Canada. The Canadian Cardiovascular Collaboration.,Canadian Journal of Cardiology,1995,,https://experts.mcmaster.ca/display/publication191170,2025-07-27T15:06:03.597100
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Feasibility and Acceptability of a Proposed Infant Feeding Intervention Trial for the Prevention of Type I Diabetes,Diabetes Care,1995,10.2337/diacare.18.7.940,https://experts.mcmaster.ca/display/publication836428,2025-07-27T15:06:03.597102
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,USERS GUIDES TO THE MEDICAL LITERATURE .7. HOW TO USE A CLINICAL DECISION-ANALYSIS .B. WHAT ARE THE RESULTS AND WILL THEY HELP ME IN CARING FOR MY PATIENTS,Journal of the American Medical Association (JAMA),1995,10.1001/jama.273.20.1610,https://experts.mcmaster.ca/display/publication1467274,2025-07-27T15:06:03.597103
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Users' guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? Evidence Based Medicine Working Group,Journal of the American Medical Association (JAMA),1995,10.1001/jama.273.20.1610,https://experts.mcmaster.ca/display/publication1463551,2025-07-27T15:06:03.597104
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,USERS GUIDES TO THE MEDICAL LITERATURE .6. HOW TO USE AN OVERVIEW,Journal of the American Medical Association (JAMA),1994,10.1001/jama.272.17.1367,https://experts.mcmaster.ca/display/publication218293,2025-07-27T15:06:03.597106
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group,Journal of the American Medical Association (JAMA),1994,10.1001/jama.272.17.1367,https://experts.mcmaster.ca/display/publication212066,2025-07-27T15:06:03.597107
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Spectrum of quality of life impairment in hypothyroidism,Quality of Life Research,1994,10.1007/bf00451724,https://experts.mcmaster.ca/display/publication190539,2025-07-27T15:06:03.597109
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,USERS GUIDES TO THE MEDICAL LITERATURE .5. HOW TO USE AN ARTICLE ABOUT PROGNOSIS,Journal of the American Medical Association (JAMA),1994,10.1001/jama.272.3.234,https://experts.mcmaster.ca/display/publication165812,2025-07-27T15:06:03.597110
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,USERS GUIDES TO THE MEDICAL LITERATURE .4. HOW TO USE AN ARTICLE ABOUT HARM,Journal of the American Medical Association (JAMA),1994,10.1001/jama.271.20.1615,https://experts.mcmaster.ca/display/publication218292,2025-07-27T15:06:03.597111
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,USERS GUIDES TO THE MEDICAL LITERATURE .3. HOW TO USE AN ARTICLE ABOUT A DIAGNOSTIC-TEST .B. WHAT ARE THE RESULTS AND WILL THEY HELP ME IN CARING FOR MY PATIENTS,Journal of the American Medical Association (JAMA),1994,10.1001/jama.271.9.703,https://experts.mcmaster.ca/display/publication218295,2025-07-27T15:06:03.597113
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group,Journal of the American Medical Association (JAMA),1994,10.1001/jama.271.9.703,https://experts.mcmaster.ca/display/publication888830,2025-07-27T15:06:03.597114
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,USERS GUIDES TO THE MEDICAL LITERATURE .3. HOW TO USE AN ARTICLE ABOUT A DIAGNOSTIC-TEST .A. ARE THE RESULTS OF THE STUDY VALID,Journal of the American Medical Association (JAMA),1994,10.1001/jama.271.5.389,https://experts.mcmaster.ca/display/publication1362157,2025-07-27T15:06:03.597116
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group,Journal of the American Medical Association (JAMA),1994,10.1001/jama.271.5.389,https://experts.mcmaster.ca/display/publication867762,2025-07-27T15:06:03.597117
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,USERS GUIDES TO THE MEDICAL LITERATURE .2. HOW TO USE AN ARTICLE ABOUT THERAPY OR PREVENTION .B. WHAT WERE THE RESULTS AND WILL THEY HELP ME IN CARING FOR MY PATIENTS,Journal of the American Medical Association (JAMA),1994,10.1001/jama.271.1.59,https://experts.mcmaster.ca/display/publication218330,2025-07-27T15:06:03.597119
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group,Journal of the American Medical Association (JAMA),1994,10.1001/jama.271.1.59,https://experts.mcmaster.ca/display/publication212083,2025-07-27T15:06:03.597120
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Cow's Milk Exposure and Type I Diabetes Mellitus: A critical overview of the clinical literature,Diabetes Care,1994,10.2337/diacare.17.1.13,https://experts.mcmaster.ca/display/publication886458,2025-07-27T15:06:03.597122
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Screening for postpartum thyroid dysfunction.,Comprehensive Therapy,1994,,https://experts.mcmaster.ca/display/publication886459,2025-07-27T15:06:03.597128
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.",CANADIAN MEDICAL ASSOCIATION JOURNAL,1993,,https://experts.mcmaster.ca/display/publication218296,2025-07-27T15:06:03.597129
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Incidence of Postpartum Thyroid Dysfunction in Patients with Type I Diabetes Mellitus,ACP journal club,1993,10.7326/0003-4819-118-6-199303150-00004,https://experts.mcmaster.ca/display/publication886460,2025-07-27T15:06:03.597131
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Exercise in the Prevention of Diabetes Mellitus in Male Physicians,Clinical Journal of Sport Medicine,1993,10.1097/00042752-199301000-00015,https://experts.mcmaster.ca/display/publication1746255,2025-07-27T15:06:03.597132
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Evidence-Based Medicine,Journal of the American Medical Association (JAMA),1992,10.1001/jama.1992.03490170092032,https://experts.mcmaster.ca/display/publication1362141,2025-07-27T15:06:03.597133
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,RISKS ASSOCIATED WITH TREATING HYPOTHYROIDISM,Canadian Family Physician,1992,,https://experts.mcmaster.ca/display/publication1375893,2025-07-27T15:06:03.597135
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Risks Associated with Treating Hypothyroidism: Potential hazards of L-thyroxine therapy.,Canadian Family Physician,1992,,https://experts.mcmaster.ca/display/publication886461,2025-07-27T15:06:03.597136
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Symptoms of hypoglycemia with human versus porcine insulin,Annals of Internal Medicine,1992,,https://experts.mcmaster.ca/display/publication1746257,2025-07-27T15:06:03.597138
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Relapse frequently occurred in Graves disease after treatment,ACP journal club,1991,10.7326/acpjc-1991-115-3-091,https://experts.mcmaster.ca/display/publication3408843,2025-07-27T15:06:03.597139
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Intensified insulin increased the risk for serious hypoglycemia and neuroglycopenia in IDDM,ACP journal club,1991,10.7326/acpjc-1991-114-3-084,https://experts.mcmaster.ca/display/publication3408844,2025-07-27T15:06:03.597141
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,3-Year effects of intensified insulin on hypoglycemia,Annals of Internal Medicine,1991,,https://experts.mcmaster.ca/display/publication1746249,2025-07-27T15:06:03.597142
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,3-Year effects of intensified insulin on hypoglycemia,Annals of Internal Medicine,1991,,https://experts.mcmaster.ca/display/publication3314839,2025-07-27T15:06:03.597143
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,How common is postpartum thyroiditis? A methodologic overview of the literature,JAMA Internal Medicine,1990,10.1001/archinte.150.7.1397,https://experts.mcmaster.ca/display/publication886462,2025-07-27T15:06:03.597154
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,IMMUNOMODULATORY EFFECT OF THE TREATMENT OF GRAVES’DISEASE ON ANTIGEN‐SPECIFIC MONOCYTE PROCOAGULANT ACTIVITY PRODUCTION,Clinical Endocrinology,1987,10.1111/j.1365-2265.1987.tb01158.x,https://experts.mcmaster.ca/display/publication886463,2025-07-27T15:06:03.597156
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.,Clinical and Investigative Medicine,1987,,https://experts.mcmaster.ca/display/publication886464,2025-07-27T15:06:03.597157
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Separate Induction of MHC and Thyroid Microsomal Antigen (McAg) Expression on Thyroid Cell Monolayers: Enhancement of Lectin-Induced McAg Expression by Interferon-γ*,Journal of Clinical Endocrinology and Metabolism (JCEM),1987,10.1210/jcem-64-6-1302,https://experts.mcmaster.ca/display/publication886465,2025-07-27T15:06:03.597158
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Sensitization of T lymphocytes to thyroid antigen in autoimmune thyroid disease as demonstrated by the monocyte procoagulant activity test,Journal of Endocrinological Investigation,1986,10.1007/bf03346969,https://experts.mcmaster.ca/display/publication886466,2025-07-27T15:06:03.597160
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Thyrocyte HLA-DR Expression and Interferon-γProduction in Autoimmune Thyroid Disease*,Journal of Clinical Endocrinology and Metabolism (JCEM),1986,10.1210/jcem-63-3-695,https://experts.mcmaster.ca/display/publication886490,2025-07-27T15:06:03.597161
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,AIDS in a patient with hemophilia receiving mainly cryoprecipitate.,CANADIAN MEDICAL ASSOCIATION JOURNAL,1984,,https://experts.mcmaster.ca/display/publication886491,2025-07-27T15:06:03.597169
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,"OGILVIE,AL - AN ATLAS OF PULPAL AND PERIAPICAL BIOLOGY",Journal of the American Dental Association,1966,,https://experts.mcmaster.ca/display/publication3523101,2025-07-27T15:06:03.597171
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,journal_articles,Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss,Yearbook of Paediatric Endocrinology,,10.1530/ey.17.11.13,https://experts.mcmaster.ca/display/publication2688170,2025-07-27T15:06:03.597172
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,chapters,Prevention of the Consequences of Diabetes – a Commentary,,2010,10.1002/9780470682807.ch15,https://experts.mcmaster.ca/display/publication1746248,2025-07-27T15:06:03.597174
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,chapters,Dysglycemia and the Risk of Cardiovascular Events,,2009,10.1002/9781444309768.ch14,https://experts.mcmaster.ca/display/publication1746247,2025-07-27T15:06:03.597176
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,chapters,Can We Change the Body Fat Distribution Phenotype? Lessons from PPAR gamma Agonists,,2009,,https://experts.mcmaster.ca/display/publication2162712,2025-07-27T15:06:03.597177
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,chapters,Gestational diabetes,,2006,,https://experts.mcmaster.ca/display/publication2169723,2025-07-27T15:06:03.597186
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,chapters,Glucose Abnormalities and Cardiovascular Disease: “Dysglycemia” as an Emerging Cardiovascular Risk Factor,,2002,10.1002/9780470986882.ch15,https://experts.mcmaster.ca/display/publication2688192,2025-07-27T15:06:03.597187
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial,EUROPEAN JOURNAL OF HEART FAILURE,2022,10.1002/ejhf.2670,https://experts.mcmaster.ca/display/publication2378480,2025-07-27T15:06:03.597191
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,ASSOCIATION BETWEEN BARIATRIC SURGERY AND ALL-CAUSE MORTALITY IN PATIENTS WITH DIABETES: A POPULATION-BASED MATCHED COHORT STUDY IN A UNIVERSAL HEALTHCARE SYSTEM Type 2 diabetes and metabolic surgery,Obesity Surgery,2022,,https://experts.mcmaster.ca/display/publication2441194,2025-07-27T15:06:03.597200
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,1102-P: Identifying Blood Biomarkers for Type 2 Diabetes Subtyping: A Report from the ORIGIN Trial,Diabetes,2022,10.2337/db22-1102-p,https://experts.mcmaster.ca/display/publication2433891,2025-07-27T15:06:03.597202
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,1263-P: Adolescent Obesity and Incident Type 1 Diabetes in Young Adulthood,Diabetes,2022,10.2337/db22-1263-p,https://experts.mcmaster.ca/display/publication2433888,2025-07-27T15:06:03.597203
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,162-LB: Cardiovascular Outcomes in People with Type 2 Diabetes and Acute Coronary Syndrome—The ELIXA Biomarker Study,Diabetes,2022,10.2337/db22-162-lb,https://experts.mcmaster.ca/display/publication2433887,2025-07-27T15:06:03.597205
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,725-P: Protein Biomarkers Associated with Dulaglutide and Cardiovascular Events in REWIND,Diabetes,2022,10.2337/db22-725-p,https://experts.mcmaster.ca/display/publication2433889,2025-07-27T15:06:03.597206
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,731-P: Metabolite Biomarkers and Cardiovascular Events in REWIND: A Post Hoc Analysis,Diabetes,2022,10.2337/db22-731-p,https://experts.mcmaster.ca/display/publication2433890,2025-07-27T15:06:03.597208
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Lixilan ONE CAN: Randomisierte Studie zum Vergleich eines täglichen vs. wöchentlichen Titrationsalgorithmus für den Wechsel von Basalinsulin zur Fixkombination iGlarLixi bei Typ-2-Diabetespatienten in Kanada,Diabetologie und Stoffwechsel,2022,10.1055/s-0042-1746286,https://experts.mcmaster.ca/display/publication2688167,2025-07-27T15:06:03.597209
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,PREDICTING DIABETES AND ITS COMPLICATIONS FROM NAILFOLD CAPILLAROSCOPY IMAGES USING DEEP LEARNING: A PILOT STUDY,Diabetes Technology and Therapeutics,2022,,https://experts.mcmaster.ca/display/publication2189596,2025-07-27T15:06:03.597210
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial,Diabetologia,2022,10.1007/s00125-021-05567-4,https://experts.mcmaster.ca/display/publication2128416,2025-07-27T15:06:03.597212
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Impact of Sodium-Glucose Co-Transporter-2 Inhibition on the Efficacy and Safety of the Glucagon-like Peptide-1 Receptor Agonist Efpeglenatide in Type 2 Diabetes,Circulation,2021,,https://experts.mcmaster.ca/display/publication2168675,2025-07-27T15:06:03.597213
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Impact of Sodium-Glucose Co-Transporter-2 Inhibition on the Efficacy and Safety of the Glucagon-like Peptide-1 Receptor Agonist Efpeglenatide in Type 2 Diabetes,Circulation,2021,,https://experts.mcmaster.ca/display/publication2175522,2025-07-27T15:06:03.597215
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"Gender differences in cardiovascular risk, treatment, and outcomes: a post-hoc analysis from the REWIND trial",Diabetologia,2021,,https://experts.mcmaster.ca/display/publication2128284,2025-07-27T15:06:03.597216
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Remission of type 2 diabetes following a short-term intervention with insulin glargine and metformin/sitagliptin: results of the REMIT-sita randomised controlled trial,Diabetologia,2021,,https://experts.mcmaster.ca/display/publication2129365,2025-07-27T15:06:03.597218
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"Remission of type 2 diabetes following intensive treatment with insulin glargine/lixisenatide, metformin and lifestyle approaches: results of the REMIT-iGlarLixi trial",Diabetologia,2021,,https://experts.mcmaster.ca/display/publication2129366,2025-07-27T15:06:03.597219
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,187-OR: Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes in the ACCORD Trial,Diabetes,2021,10.2337/db21-187-or,https://experts.mcmaster.ca/display/publication2162111,2025-07-27T15:06:03.597220
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial",Diabetes,2021,10.2337/db21-677-p,https://experts.mcmaster.ca/display/publication2162110,2025-07-27T15:06:03.597222
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,95-LB: LixilanONE CAN: Randomized Trial Comparing a Daily vs. Weekly Titration Algorithm for Switching from Basal Insulin to iGlarLixi Fixed-Ratio Combination in People with T2DM in Canada,Diabetes,2021,10.2337/db21-95-lb,https://experts.mcmaster.ca/display/publication2162109,2025-07-27T15:06:03.597223
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,EASE OF USING IGLARLIXI PEN AFTER INSULIN GLARGINE GLA-100: RESULTS FROM PATIENT AND HEALTHCARE PROVIDER QUESTIONNAIRES FROM THE ONE CAN PEN SUB-STUDY,Diabetes Technology and Therapeutics,2021,,https://experts.mcmaster.ca/display/publication1983963,2025-07-27T15:06:03.597225
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Burden of Cardiovascular or Fatal Outcomes in People With Type 2 Diabetes and Cardiovascular Risk Factors Treated With Dulaglutide a Post Hoc Analysis From the Rewind Trial,Circulation,2020,,https://experts.mcmaster.ca/display/publication1962176,2025-07-27T15:06:03.597226
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Cardiovascular outcomes in patients with type 2 diabetes and reduced eGFR and albuminuria: a REWIND post hoc subgroup analysis,European Heart Journal,2020,10.1093/ehjci/ehaa946.3350,https://experts.mcmaster.ca/display/publication1962178,2025-07-27T15:06:03.597228
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Dulaglutide is cardioprotective with or without background metformin in patients with diabetes and established or high risk for coronary vascular disease. A subgroup analysis of the REWIND Trial,European Heart Journal,2020,10.1093/ehjci/ehaa946.3353,https://experts.mcmaster.ca/display/publication1962177,2025-07-27T15:06:03.597229
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,The Effect of Diabetes Health Coaching on Glycemic Control and Quality of Life in Adults Living With Type 2 Diabetes: A Community-Based Randomized Controlled Trial,Canadian Journal of Diabetes,2020,10.1016/j.jcjd.2020.08.005,https://experts.mcmaster.ca/display/publication1959211,2025-07-27T15:06:03.597231
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Cardio protection with dulaglutide is not depending on baseline therapy with metformin: a subgroup analysis of the REWIND trial,Diabetologia,2020,,https://experts.mcmaster.ca/display/publication1927545,2025-07-27T15:06:03.597232
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Cardiovascular outcomes in patients with type 2 diabetes and reduced eGFR and albuminuria: a REWIND post hoc subgroup analysis,Diabetologia,2020,,https://experts.mcmaster.ca/display/publication1927544,2025-07-27T15:06:03.597234
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"Dulaglutide reduces HbA(1c) irrespective of antihyperglycaemic agents, duration of diabetes, BMI and weight loss: a post hoc analysis from the REWIND trial",Diabetologia,2020,,https://experts.mcmaster.ca/display/publication1927302,2025-07-27T15:06:03.597235
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Effect of dulaglutide on kidney function-related outcomes in type 2 diabetes: post hoc analysis from the REWIND trial,Diabetologia,2020,,https://experts.mcmaster.ca/display/publication1927546,2025-07-27T15:06:03.597236
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Effects of intensive risk factor management on cardiovascular autonomic neuropathy in type 2 diabetes: findings from the ACCORD clinical trial,Diabetologia,2020,,https://experts.mcmaster.ca/display/publication1927543,2025-07-27T15:06:03.597238
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Exploring potential mediators of the cardiovascular benefit of dulaglutide in REWIND,Diabetologia,2020,,https://experts.mcmaster.ca/display/publication1927547,2025-07-27T15:06:03.597241
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,130-OR: Effects of Intensive Risk Factor Management on Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: Findings from the ACCORD Trial,Diabetes,2020,10.2337/db20-130-or,https://experts.mcmaster.ca/display/publication1927540,2025-07-27T15:06:03.597243
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,1421-P: The Impact of Blood Pressure on Risk of Death Is Influenced by Prior Cardiovascular Disease in Patients with Type 2 Diabetes and a Recent Coronary Event,Diabetes,2020,10.2337/db20-1421-p,https://experts.mcmaster.ca/display/publication1927541,2025-07-27T15:06:03.597244
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,356-OR: Effect of Dulaglutide on Kidney Function–Related Outcomes in Type 2 Diabetes: Post Hoc Analysis from the REWIND Trial,Diabetes,2020,10.2337/db20-356-or,https://experts.mcmaster.ca/display/publication1927542,2025-07-27T15:06:03.597246
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,924-P: Exploring Potential Mediators of the Cardiovascular Benefit of Dulaglutide in REWIND,Diabetes,2020,10.2337/db20-924-p,https://experts.mcmaster.ca/display/publication1927538,2025-07-27T15:06:03.597247
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,944-P: HbA1c Change Is Associated with Retinopathy Outcomes during GLP-1RA CVOT Follow-Up,Diabetes,2020,10.2337/db20-944-p,https://experts.mcmaster.ca/display/publication1927539,2025-07-27T15:06:03.597248
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"DULAGLUTIDE REDUCES HBA1C IRRESPECTIVE OF ANTIHYPERGLYCEMIC AGENTS, DURATION OF DIABETES, BMI AND WEIGHT LOSS: A POST HOC ANALYSIS FROM THE REWIND TRIAL",Journal of the American College of Cardiology,2020,10.1016/s0735-1097(20)32578-x,https://experts.mcmaster.ca/display/publication1813271,2025-07-27T15:06:03.597250
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Influence of Genetic Ancestry on Human Serum Proteome,American Journal of Human Genetics,2020,10.1016/j.ajhg.2020.01.016,https://experts.mcmaster.ca/display/publication1672731,2025-07-27T15:06:03.597251
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Are the Beneficial Cardiovascular Effects of Glucagon-Like Peptide 1 Receptor Agonists in Diabetic Patients Metabolically Mediated?,Circulation,2019,,https://experts.mcmaster.ca/display/publication1689200,2025-07-27T15:06:03.597253
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Angiotensin-converting enzyme and type 2 diabetes risk: a Mendelian randomisation study,Diabetologia,2019,,https://experts.mcmaster.ca/display/publication1671000,2025-07-27T15:06:03.597254
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"Diabetes regression and remission following a short-term intensive metabolic intervention with insulin glargine, metformin and dapagliflozin",Diabetologia,2019,,https://experts.mcmaster.ca/display/publication1670104,2025-07-27T15:06:03.597255
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Novel biomarkers predicting renal decline in people with dysglycaemia in the ORIGIN trial,Diabetologia,2019,,https://experts.mcmaster.ca/display/publication1671151,2025-07-27T15:06:03.597257
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,1506-P: Breast Cancer as a Risk Factor for New Diabetes,Diabetes,2019,10.2337/db19-1506-p,https://experts.mcmaster.ca/display/publication1686976,2025-07-27T15:06:03.597258
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,240-LB: Angiotensin-Converting Enzyme and Type 2 Diabetes Risk: A Mendelian Randomization Study,Diabetes,2019,10.2337/db19-240-lb,https://experts.mcmaster.ca/display/publication1686977,2025-07-27T15:06:03.597259
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,254-OR: Novel Biomarkers Predicting Renal Dysfunction in People with Dysglycemia in the ORIGIN Trial,Diabetes,2019,10.2337/db19-254-or,https://experts.mcmaster.ca/display/publication1686975,2025-07-27T15:06:03.597261
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"DYSGLYCEMIA, EJECTION FRACTION, AND THE RISK OF HEART FAILURE OR CARDIOVASCULAR DEATH IN PATIENTS WITH TYPE 2 DIABETES AND A RECENT ACUTE CORONARY SYNDROME",Journal of the American College of Cardiology,2019,10.1016/s0735-1097(19)31381-6,https://experts.mcmaster.ca/display/publication1634570,2025-07-27T15:06:03.597297
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,TESTOSTERONE AND SEX HORMONE-BINDING GLOBULIN IN DYSGLYCEMIC WOMEN AT HIGH CARDIOVASCULAR RISK: A REPORT FROM THE OUTCOME REDUCTION WITH AN INITIAL GLARGINE INTERVENTION TRIAL,Journal of the American College of Cardiology,2019,10.1016/s0735-1097(19)32366-6,https://experts.mcmaster.ca/display/publication1634569,2025-07-27T15:06:03.597304
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)",Diabetologia,2018,,https://experts.mcmaster.ca/display/publication1596092,2025-07-27T15:06:03.597307
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Effect of free testosterone levels on cardiovascular outcomes: a Mendelian randomization analysis,European Heart Journal,2018,,https://experts.mcmaster.ca/display/publication1634474,2025-07-27T15:06:03.597311
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Neighborhood Walkability and Diabetes-Related Complications,Diabetes,2018,10.2337/db18-309-or,https://experts.mcmaster.ca/display/publication1637498,2025-07-27T15:06:03.597314
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Testosterone Levels and Risk for Cardiovascular Events - A Report From the ORIGIN (Outcome Reduction With an Initial Glargine Intervention) Trial,Circulation,2017,,https://experts.mcmaster.ca/display/publication1586280,2025-07-27T15:06:03.597317
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Item reduction and validation of the Chinese version of Diabetes Quality-of-Life Measure (DQOL),Quality of Life Research,2017,,https://experts.mcmaster.ca/display/publication1535060,2025-07-27T15:06:03.597320
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,IGFBP-3 is a marker of impaired adipose tissue function and a novel causal mediator of type 2 diabetes risk: a report from the ORIGIN study,Diabetologia,2017,,https://experts.mcmaster.ca/display/publication1467885,2025-07-27T15:06:03.597322
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Novel biomarkers predicting heart failure hospitalisation in people with dysglycaemia in the ORIGIN trial,Diabetologia,2017,,https://experts.mcmaster.ca/display/publication1467275,2025-07-27T15:06:03.597325
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,CHANGES IN THE INTRA-ABDOMINAL FAT DEPOTS AND ASSOCIATIONS WITH GLYCEMIC PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES UNDERGOING BARIATRIC SURGERY Type 2 diabetes and metabolic surgery,Obesity Surgery,2017,,https://experts.mcmaster.ca/display/publication1635391,2025-07-27T15:06:03.597336
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Genetic Predictors of Cardiovascular Outcomes during Intensive Blood Pressure Control in ACCORD,Diabetes,2017,,https://experts.mcmaster.ca/display/publication1457247,2025-07-27T15:06:03.597339
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Novel Biomarkers Predicting Heart Failure Hospitalization in People with Dysglycemia in the ORIGIN Trial,Diabetes,2017,,https://experts.mcmaster.ca/display/publication1457246,2025-07-27T15:06:03.597342
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Statistical considerations for analyzing multiplex biomarker data from prospective studies,Trials,2017,,https://experts.mcmaster.ca/display/publication1462694,2025-07-27T15:06:03.597345
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Increases in natriuretic peptides precede heart failure hospitalization in patients with a recent coronary event and type 2 diabetes,EUROPEAN JOURNAL OF HEART FAILURE,2017,,https://experts.mcmaster.ca/display/publication1375844,2025-07-27T15:06:03.597353
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"Mendelian Randomization (MR) Predicts a Causal Role for Serum ACE, APOC-1, APOE, Clusterin, and GDF-15 in Alzheimer Disease (AD)",Genetic Epidemiology,2016,,https://experts.mcmaster.ca/display/publication208851,2025-07-27T15:06:03.597356
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Changes in BNP prior to major cardiovascular events in patients with type 2 diabetes and a recent coronary event,European Heart Journal,2016,,https://experts.mcmaster.ca/display/publication1375848,2025-07-27T15:06:03.597359
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Effects of lixisenatide on natriuretic peptides in patients with diabetes and acute coronary syndrome,Diabetologia,2016,,https://experts.mcmaster.ca/display/publication1375845,2025-07-27T15:06:03.597362
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Identification of blood CSF1 and CXCL12 as new causal mediators of coronary artery disease using Mendelian randomization in the ORIGIN trial,European Heart Journal,2016,,https://experts.mcmaster.ca/display/publication208840,2025-07-27T15:06:03.597365
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Novel biomarkers predicting a microvascular composite outcome in people with dysglycaemia in the ORIGIN trial,Diabetologia,2016,,https://experts.mcmaster.ca/display/publication208838,2025-07-27T15:06:03.597367
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Performance of the validated ORIGIN cardiovascular biomarker panel in HOPE study participants with diabetes,Diabetologia,2016,,https://experts.mcmaster.ca/display/publication208835,2025-07-27T15:06:03.597370
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,BNP Enhances Predictive Models of Cardiovascular Outcomes in Patients with Type 2 Diabetes and a Recent Coronary Event,Diabetes,2016,,https://experts.mcmaster.ca/display/publication1375846,2025-07-27T15:06:03.597373
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Genetic Predictors of Cardiovascular Mortality during Intensive Glycemic Control in Type 2 Diabetes,Diabetes,2016,,https://experts.mcmaster.ca/display/publication1375850,2025-07-27T15:06:03.597376
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Novel Biomarkers Predicting a Microvascular Composite Outcome in People with Dysglycemia in the ORIGIN Trial,Diabetes,2016,,https://experts.mcmaster.ca/display/publication208837,2025-07-27T15:06:03.597379
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Performance of the Validated ORIGIN Cardiovascular Biomarker Panel in HOPE Study Participants with Diabetes,Diabetes,2016,,https://experts.mcmaster.ca/display/publication208834,2025-07-27T15:06:03.597381
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Predictors of Remission of Type 2 Diabetes following a Short-Term Intensive Metabolic Intervention,Diabetes,2015,,https://experts.mcmaster.ca/display/publication751903,2025-07-27T15:06:03.597384
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Self-Perceived Distress and Diabetes Risk among Young Men,Diabetes,2015,,https://experts.mcmaster.ca/display/publication1375851,2025-07-27T15:06:03.597387
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Effects of Insulin Glargine on Left Ventricular Mass and Function in Patients With Dysglycemia,Circulation,2014,,https://experts.mcmaster.ca/display/publication978819,2025-07-27T15:06:03.597390
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Outcome reduction with an initial glargine intervention and legacy effects (ORIGINALE),Diabetologia,2014,,https://experts.mcmaster.ca/display/publication751884,2025-07-27T15:06:03.597392
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"Clinical and Biochemical Markers of Nonprogression to Type 2 Diabetes Mellitus from a ""Prediabetes"" Stage",Diabetes,2014,,https://experts.mcmaster.ca/display/publication231494,2025-07-27T15:06:03.597395
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Perinatal Exposure to the Selective Serotonin Reuptake Inhibitor Fluoxetine Results in Hepatic Lipid Accumulation and Inflammation,Endocrine Reviews,2014,,https://experts.mcmaster.ca/display/publication1375853,2025-07-27T15:06:03.597398
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Prevalence and Determinants of Peripheral Neuropathy and Nerve Dysfunction in a Population at High Risk for Type 2 Diabetes-The PROMISE Cohort,Diabetes,2014,,https://experts.mcmaster.ca/display/publication1375858,2025-07-27T15:06:03.597400
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Effects of n-3 fatty acids on long-term outcomes of high risk patients with type 2 diabetes mellitus or IGF/IGT with a recent myocardial infarction,European Heart Journal,2013,,https://experts.mcmaster.ca/display/publication1375860,2025-07-27T15:06:03.597403
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Association of Differential White Blood Cell Count With Insulin Resistance and beta-Cell Dysfunction-The PROMISE Cohort,Diabetes,2013,,https://experts.mcmaster.ca/display/publication1375856,2025-07-27T15:06:03.597406
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Cancer Outcomes in Patients With Dysglycemia on Basal Insulin: Results of the ORIGIN Trial,Diabetes,2013,,https://experts.mcmaster.ca/display/publication962637,2025-07-27T15:06:03.597408
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Cancer Outcomes in Patients With Dysglycemia on Basal Insulin: Results of the ORIGIN Trial,Diabetes,2013,,https://experts.mcmaster.ca/display/publication962638,2025-07-27T15:06:03.597411
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Effect of Basal Insulin Glargine and Omega 3 FA on Cognitive Decline and Dementia in People With Dysglycemia,Diabetes,2013,,https://experts.mcmaster.ca/display/publication1375857,2025-07-27T15:06:03.597414
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Handgrip Strength Is Associated With Glomerular Filtration Rate in Patients With Diabetes Type 2,Diabetes,2013,,https://experts.mcmaster.ca/display/publication1389648,2025-07-27T15:06:03.597416
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Handgrip Strength Predicts Cardiovascular Mortality: A Subanalysis of the ORIGIN Trial,Diabetes,2013,,https://experts.mcmaster.ca/display/publication1389644,2025-07-27T15:06:03.597419
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,The Association of Leg Length With Metabolic Abnormalities Underlying Type 2 Diabetes Mellitus: The PROMISE Cohort,Diabetes,2013,,https://experts.mcmaster.ca/display/publication1375855,2025-07-27T15:06:03.597421
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"A new in vivo methodology for quantifying intramuscular adipose tissue (IMAT) in the lower leg of women to define the relationship with BMD, strength, physical function and lifestyle variables",Journal of Bone and Mineral Research,2013,,https://experts.mcmaster.ca/display/publication232178,2025-07-27T15:06:03.597424
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,422 Accelerated Adipose Tissue Dysfunction and Cardiovascular Risk in Individuals of South Asian Ethnicity,Canadian Journal of Cardiology,2012,10.1016/j.cjca.2012.07.397,https://experts.mcmaster.ca/display/publication201360,2025-07-27T15:06:03.597432
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,IS ACCELERATED ATHEROSCLEROSIS A MICROVASCULAR COMPLICATION OF DIABETES?,Canadian Journal of Cardiology,2012,,https://experts.mcmaster.ca/display/publication526591,2025-07-27T15:06:03.597435
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Alanine Transaminase and Waist to Hip Ratio Predict Regression to Normoglycemia and AUC(glucose0-120 min) in Adult Patients With Prediabetes,Diabetes,2012,,https://experts.mcmaster.ca/display/publication199547,2025-07-27T15:06:03.597438
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Changes in Adiposity Predict Changes in Serum 25(OH)D Over 3 Years of Follow-up: The PROspective Metabolism and Islet Cell Evaluation (PROMISE) Cohort Study,Diabetes,2012,,https://experts.mcmaster.ca/display/publication1375847,2025-07-27T15:06:03.597440
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Evaluating the Feasibility and Impact of an Internet-Based Lifestyle Modification Program in a Clinical Setting,Diabetes,2012,,https://experts.mcmaster.ca/display/publication787348,2025-07-27T15:06:03.597443
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Fetal Exposure to the Selective Serotonin Reuptake Inhibitor Sertraline Results in Impaired Fetal Growth and Pancreatic Development in Wistar Rats,Reproductive Sciences,2012,,https://experts.mcmaster.ca/display/publication1375859,2025-07-27T15:06:03.597448
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial,Diabetologia,2011,,https://experts.mcmaster.ca/display/publication1375824,2025-07-27T15:06:03.597451
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Postnatal Reproductive Health Following Fetal and Neonatal Exposure to the Smoking Cessation Drug Bupropion,Journal of Developmental Origins of Health and Disease,2011,,https://experts.mcmaster.ca/display/publication625791,2025-07-27T15:06:03.597454
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Alanine Aminotransferase and Progression of Insulin Resistance and Beta Cell Dysfunction,Diabetes,2011,,https://experts.mcmaster.ca/display/publication1636260,2025-07-27T15:06:03.597456
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Is Insulin Exposure Associated with Higher Risk of Cancer-Related Hospitalization or Death? Analysis of 5-Year Data from the ACCORD Trial,Diabetes,2011,,https://experts.mcmaster.ca/display/publication1636261,2025-07-27T15:06:03.597459
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Piloting a Novel Algorithm for Glucose Control in the Coronary Care Unit: The RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) Trial,Diabetes,2011,,https://experts.mcmaster.ca/display/publication1636258,2025-07-27T15:06:03.597462
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Prospective Association of Vitamin D with Beta-Cell Function and Glycemia,Diabetes,2011,,https://experts.mcmaster.ca/display/publication1636259,2025-07-27T15:06:03.597465
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Incident cancers in people with dysglycemia and other cardiovascular risk factors: Cohort study of the ORIGIN trial.,Journal of Clinical Oncology,2011,10.1200/jco.2011.29.15_suppl.1504,https://experts.mcmaster.ca/display/publication962643,2025-07-27T15:06:03.597468
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Postnatal Metabolic Health Following Fetal and Neonatal Exposure to the Antidepressant Bupropion.,Reproductive Sciences,2011,,https://experts.mcmaster.ca/display/publication1375820,2025-07-27T15:06:03.597470
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,INVESTIGATING THE PRO-ATHEROGENIC POTENTIAL OF CHRONIC HYPERGLYCAEMIA: IS DIABETIC ATHEROSCLEROSIS A MICROVASCULAR COMPLICATION?,Canadian Journal of Cardiology,2010,,https://experts.mcmaster.ca/display/publication526620,2025-07-27T15:06:03.597473
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Evaluation of intra-stent neointima hyperplasia in the approach trial (assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history),European Heart Journal,2009,,https://experts.mcmaster.ca/display/publication1375868,2025-07-27T15:06:03.597476
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Once-daily insulin glargine requires a significantly lower dose than insulin detemir twice daily to achieve good glycaemic control in patients with type 2 diabetes failing oral therapy,Diabetologia,2009,,https://experts.mcmaster.ca/display/publication1375882,2025-07-27T15:06:03.597479
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Prevalence & prognostic importance of micro-& macro-albuminuria in heart failure- an analysis from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Programme,European Heart Journal,2009,,https://experts.mcmaster.ca/display/publication1375866,2025-07-27T15:06:03.597482
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Serial assessments of coronary remodeling from the approach trial (assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history),European Heart Journal,2009,,https://experts.mcmaster.ca/display/publication1375863,2025-07-27T15:06:03.597484
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Association of Hematological Parameters with Insulin Sensitivity and beta-Cell Dysfunction in Non-Diabetic Subjects,Diabetes,2009,,https://experts.mcmaster.ca/display/publication1375877,2025-07-27T15:06:03.597487
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Cardiac Autonomic Dysfunction Prodicts Cardiovascular Mortality in the Action To Control Cardiovascular Risk in Diabetes (ACCORD) Trial,Diabetes,2009,,https://experts.mcmaster.ca/display/publication1375878,2025-07-27T15:06:03.597490
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Effect of Rosiglitazone and Ramipril on beta-Cell Function in Subjects with Impaired Glucose Tolerance (IGT) or Impaired Fasting Glucose (IFG): The DREAM Trial,Diabetes,2009,,https://experts.mcmaster.ca/display/publication1375880,2025-07-27T15:06:03.597492
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Impact of Ramipril on Body Fat Compartments and Hepatic Fat in the DREAM Trial,Diabetes,2009,,https://experts.mcmaster.ca/display/publication231491,2025-07-27T15:06:03.597495
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Impact of Rosiglitazone on Body Fat Compartments and Hepatic Fat in the DREAM Trial,Diabetes,2009,,https://experts.mcmaster.ca/display/publication231488,2025-07-27T15:06:03.597497
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,The Relationship between Dysglycemia Category and Cognitive Function: The ORIGIN Cognitive Sub-Study,Diabetes,2009,,https://experts.mcmaster.ca/display/publication1375876,2025-07-27T15:06:03.597500
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"QL3 ESTIMATION OF UTILITY VALUES FOR DIABETESXD-RELATED COMPLICATIONS ON QUALITY OF LIFE FOR PATIENTS WITH TYPE-2 DIABETES IN ONTARIO, CANADA",Value in Health,2009,10.1016/s1098-3015(10)73144-2,https://experts.mcmaster.ca/display/publication360379,2025-07-27T15:06:03.597503
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Differential Clinical Outcomes Associated With Hypoglycemia and Hyperglycemia in Acute Myocardial Infarction,Journal of the American College of Cardiology,2009,,https://experts.mcmaster.ca/display/publication1375879,2025-07-27T15:06:03.597506
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Effect of Rosiglitazone on Left Ventricular Systolic and Diastolic Function and on NT-proBNP: Results of the Echocardiographic and Biomarker Substudy of the DREAM Trial,Circulation,2008,,https://experts.mcmaster.ca/display/publication1375890,2025-07-27T15:06:03.597509
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Digestive Disease Week and American Diabetes Association: Action to Control Cardiovascular Risk (ACCORD) Trial,P and T,2008,,https://experts.mcmaster.ca/display/publication1746265,2025-07-27T15:06:03.597511
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Whole 24-hour continuous glucose monitoring profiles with insulin glargine or oral antidiabetic drug therapy in patients with type 2 diabetes mellitus,Diabetologia,2008,,https://experts.mcmaster.ca/display/publication1375830,2025-07-27T15:06:03.597514
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,An oral glucose challenge induces endoplasmic reticulum stress in circulating blood cells and vascular tissue: A possible mechanism linking postprandial hyperglycemia to cardiovascular risk,Diabetes,2008,,https://experts.mcmaster.ca/display/publication1375825,2025-07-27T15:06:03.597517
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Diabetes management in Canada: Evidence of an ongoing care gap,Diabetes,2008,,https://experts.mcmaster.ca/display/publication1521625,2025-07-27T15:06:03.597519
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Echocardiographic epicardial fat predicts the metabolic syndrome,Diabetes,2008,,https://experts.mcmaster.ca/display/publication1521631,2025-07-27T15:06:03.597522
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Frailty grip is associated with glucose intolerance: Results from the epidemiological DREAM study population,Diabetes,2008,,https://experts.mcmaster.ca/display/publication413007,2025-07-27T15:06:03.597525
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Management of vascular risk factors in a cohort of patients with type 2 diabetes mellitus (DM) in Canada: Significant gap between guidelines recommendations and current practice,Diabetes,2008,,https://experts.mcmaster.ca/display/publication1521624,2025-07-27T15:06:03.597527
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,The relationship between baseline HbA1c levels and cognitive function in people with type 2 diabetes and other cardiovascular risk factors: The ACCORD-MIND study,Diabetes,2008,,https://experts.mcmaster.ca/display/publication1375829,2025-07-27T15:06:03.597530
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Whole 24-hour continuous glucose monitoring (CGM) profiles with insulin glargine or oral antidiabetic drug (OAD) therapy in patients with type 2 diabetes mellitus (T2DM),Diabetes,2008,,https://experts.mcmaster.ca/display/publication1375827,2025-07-27T15:06:03.597532
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"Elevated in-hospital glucose level, and not known history of diabetes mellitus, predicts 30-day mortality following acute ST-elevation myocardial infarction",Circulation,2007,,https://experts.mcmaster.ca/display/publication1375833,2025-07-27T15:06:03.597535
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Glucose levels predict incident cardiovascular events in a large international multiethnic cohort,Circulation,2007,,https://experts.mcmaster.ca/display/publication212337,2025-07-27T15:06:03.597537
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Obesity metrics and their associations with type 2 diabetes and glucose levels in a large international multi-ethnic cohort,Circulation,2007,,https://experts.mcmaster.ca/display/publication212336,2025-07-27T15:06:03.597540
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Glycemic control after angioplasty reduces stent restenosis in patients with diabetes: Results of the stent restenosis and metabolism (stream) study,Canadian Journal of Cardiology,2007,,https://experts.mcmaster.ca/display/publication455995,2025-07-27T15:06:03.597543
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,The effect of rosiglitazone on peripheral insulin signaling and glucose utilization pathways following fetal and neonatal exposure to nicotine in rats,Diabetes,2007,,https://experts.mcmaster.ca/display/publication1375828,2025-07-27T15:06:03.597545
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,A plea for intra-laboratory reference limits. Part 2. A bimodal retrospective concept for determining reference limits from intra-laboratory databases demonstrated by catalytic activity concentrations of enzymes,Clinical Chemistry and Laboratory Medicine,2007,10.1515/cclm.2007.250,https://experts.mcmaster.ca/display/publication455111,2025-07-27T15:06:03.597548
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the heart outcomes prevention evaluation (HOPE) Study,Circulation,2006,,https://experts.mcmaster.ca/display/publication161834,2025-07-27T15:06:03.597550
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Fasting plasma glucose is an independent predictor of hospitalization for congestive heart failure in high-risk patients,Circulation,2006,,https://experts.mcmaster.ca/display/publication542913,2025-07-27T15:06:03.597553
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Diabetes status and fasting plasma glucose are independent determinants of cognitive status in people at high risk for cardiovascular disease,Diabetologia,2006,,https://experts.mcmaster.ca/display/publication543012,2025-07-27T15:06:03.597556
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Fasting glucose as a predictor of cardiovascular events in high-risk patients,European Heart Journal,2006,,https://experts.mcmaster.ca/display/publication542979,2025-07-27T15:06:03.597558
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Fasting plasma glucose and new onset of diabetes type 2 in high-risk patients,European Heart Journal,2006,,https://experts.mcmaster.ca/display/publication543006,2025-07-27T15:06:03.597566
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,A systematic review and meta-analysis of hypoglycemia and cardiovascular events: A comparison of glyburide with other secretagogues and with insulin,Diabetes,2006,,https://experts.mcmaster.ca/display/publication455277,2025-07-27T15:06:03.597569
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia,Diabetes,2006,,https://experts.mcmaster.ca/display/publication1375834,2025-07-27T15:06:03.597571
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,PDB57 TREATMENT SATISFACTION AND QUALITY OF LIFE WITH AN EARLY INSULINIZATION STRATEGYWITH INSULIN GLARGINE COMPARED TO AN ADJUSTED ORAL THERAPY IN THE MANAGEMENT OF TYPE-2 DIABETES: THE CANADIAN INSIGHT STUDY,Value in Health,2005,10.1016/s1098-3015(10)67674-7,https://experts.mcmaster.ca/display/publication1375840,2025-07-27T15:06:03.597574
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Prevention of diabetes in schizophrenia: A review of the scope and limitations,Schizophrenia Bulletin,2005,,https://experts.mcmaster.ca/display/publication1123436,2025-07-27T15:06:03.597577
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,A Randomized trial of early glargine use to achieve optimal Alc levels in insulin naive people with type 2 diabetes,Diabetes,2005,,https://experts.mcmaster.ca/display/publication1375843,2025-07-27T15:06:03.597579
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Cognitive decline in diabetes - A systematic overview and meta-analysis of observational studies,Diabetes,2005,,https://experts.mcmaster.ca/display/publication1375841,2025-07-27T15:06:03.597582
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Efficacy and safety of glargine insulin in primary care,Diabetologia,2005,,https://experts.mcmaster.ca/display/publication1521627,2025-07-27T15:06:03.597584
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Glucose control during early insulinization with glargine as assessed by the continuous glucose monitoring system (CGMS),Diabetologia,2005,,https://experts.mcmaster.ca/display/publication1521628,2025-07-27T15:06:03.597586
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Does Substitution of T4 with T3 Plus T4 for T4 Replacement Improve Depressive Symptoms in Patients with Hypothyroidism?,Annals of the New York Academy of Sciences,2004,10.1196/annals.1314.040,https://experts.mcmaster.ca/display/publication1396424,2025-07-27T15:06:03.597589
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Thyroid function screening following radiation therapy for cancers of the head and neck: A survey of Canadian practice patterns,Radiotherapy and Oncology,2004,,https://experts.mcmaster.ca/display/publication1507675,2025-07-27T15:06:03.597597
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Design and baseline characteristics of the DREAM (diabetes REduction assessment with ramipril and rosiglitazone medication) trial,Diabetes,2004,,https://experts.mcmaster.ca/display/publication1375854,2025-07-27T15:06:03.597600
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Glucose & incident CVD in diabetic & nondiabetic patients on dialysis: Data from the GARRD study,Diabetes,2004,,https://experts.mcmaster.ca/display/publication1365960,2025-07-27T15:06:03.597602
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,810-1 Impact of the angiotensin-receptor blocker candesartan in preventing diabetes in patients with heart failure,Journal of the American College of Cardiology,2004,10.1016/s0735-1097(04)92003-7,https://experts.mcmaster.ca/display/publication1389615,2025-07-27T15:06:03.597606
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk diabetic patients,Journal of the American College of Cardiology,2002,10.1016/s0735-1097(02)81305-5,https://experts.mcmaster.ca/display/publication1389423,2025-07-27T15:06:03.597608
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Impact of abdominal obesity on the occurrence of diabetes in subjects with ischemic cardiovascular disease,Circulation,2001,,https://experts.mcmaster.ca/display/publication1375889,2025-07-27T15:06:03.597611
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Meal-based repaglinide therapy in type 2 diabetes can be titrated using either preprandial or postprandial blood glucose to maximize glycemic control,Diabetes,2001,,https://experts.mcmaster.ca/display/publication1375885,2025-07-27T15:06:03.597617
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Metabolic and hematological effects of ramipril in the HOPE trial,Circulation,2000,,https://experts.mcmaster.ca/display/publication191142,2025-07-27T15:06:03.597620
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Renal insufficiency as a predictor of cardiovascular outcomes and impact of ramipril: The HOPE study,Circulation,2000,,https://experts.mcmaster.ca/display/publication1375886,2025-07-27T15:06:03.597623
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Differences in cardiovascular disease between ethnic groups are not explained by conventional risk factors or atherosclerosis. The study of health assessment and risk in ethnic groups (SHARE),Journal of the American College of Cardiology,2000,,https://experts.mcmaster.ca/display/publication202411,2025-07-27T15:06:03.597625
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Ramipril prevents cardiovascular events in high risk diabetic participants: Results of the HOPE study,Journal of the American College of Cardiology,2000,,https://experts.mcmaster.ca/display/publication1375875,2025-07-27T15:06:03.597628
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS registry,Circulation,1999,,https://experts.mcmaster.ca/display/publication1390040,2025-07-27T15:06:03.597631
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,The efficacy and safety of acarbose in the treatment of type 2 diabetes mellitus in elderly patients.,Diabetologia,1999,,https://experts.mcmaster.ca/display/publication1365177,2025-07-27T15:06:03.597633
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent,Canadian Journal of Physiology and Pharmacology,1999,10.1139/cjpp-77-2-118,https://experts.mcmaster.ca/display/publication1375881,2025-07-27T15:06:03.597636
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Stress hyperglycemia and prognosis of myocardial infarction in nondiabetic and diabetic patients: a systematic overview,Diabetes,1999,,https://experts.mcmaster.ca/display/publication1375888,2025-07-27T15:06:03.597639
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview,Diabetes,1999,,https://experts.mcmaster.ca/display/publication1375884,2025-07-27T15:06:03.597641
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Albuminuria is highly prevalent and predicts cardiovascular events in high risk diabetic and nondiabetic patients,Circulation,1997,,https://experts.mcmaster.ca/display/publication1375895,2025-07-27T15:06:03.597644
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"A one day continuing medical education workshop improves primary care physicians' attitude, knowledge and self-reported practice patterns regarding diabetes.",Diabetes,1997,,https://experts.mcmaster.ca/display/publication1350874,2025-07-27T15:06:03.597646
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Hydroxychloroquine improves glycemic control in NIDDM.,Diabetes,1997,,https://experts.mcmaster.ca/display/publication1348304,2025-07-27T15:06:03.597649
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,"Continuous relationship of glucose with cardiovascular events in non diabetic subjects: A meta regression analysis of 18 studies in 88,000 individuals.",Circulation,1996,,https://experts.mcmaster.ca/display/publication1375896,2025-07-27T15:06:03.597693
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,Diabetes is an independent risk factor for increased left ventricular mass,Circulation,1996,,https://experts.mcmaster.ca/display/publication1375892,2025-07-27T15:06:03.597696
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,MICROALBUMINURIA AND MORTALITY IN NIDDM - A SYSTEMATIC OVERVIEW OF THE LITERATURE,Diabetes,1995,,https://experts.mcmaster.ca/display/publication1521629,2025-07-27T15:06:03.597698
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,SEPARATE INDUCTION OF MHC AND THYROID MICROSOMAL ANTIGEN (MCAG) EXPRESSION ON THYROID-CELL MONOLAYERS - ENHANCEMENT OF LECTIN-INDUCED MCAG EXPRESSION BY INTERFERON-GAMMA,Annales d'Endocrinologie,1987,,https://experts.mcmaster.ca/display/publication1375887,2025-07-27T15:06:03.597700
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,NUCLEAR AND CYTOPLASMIC RNA-PROTEIN COMPLEXES FROM INFLUENZA-VIRUS INFECTED-CELLS,Journal of Cell Biology,1976,,https://experts.mcmaster.ca/display/publication1521640,2025-07-27T15:06:03.597701
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,conferences,BACTERIOSTATIC ACTIVITY + HISTOPATHOLOGICAL EFFECTS OF ENDODONTIC THERAPEUTIC AGENTS,Journal of Dental Research,1964,,https://experts.mcmaster.ca/display/publication3523102,2025-07-27T15:06:03.597703
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,preprints,"Proteome-wide Mendelian randomization study implicates inflammaging biomarkers in retinal vasculature, cardiometabolic diseases and longevity",,2024,10.1101/2024.07.13.24310153,https://experts.mcmaster.ca/display/publication3453837,2025-07-27T15:06:03.597705
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,preprints,Large and small peripheral arterial disease in persons with type 2 diabetes,,2023,10.1101/2023.06.01.23290852,https://experts.mcmaster.ca/display/publication3408839,2025-07-27T15:06:03.597706
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,preprints,Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications,,2023,10.1101/2023.03.31.23287839,https://experts.mcmaster.ca/display/publication3234412,2025-07-27T15:06:03.597708
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,preprints,Global variation in tests of cognitive and physical function: analysis of six international randomized controlled trials,,2023,10.1101/2023.01.05.22284064,https://experts.mcmaster.ca/display/publication3241522,2025-07-27T15:06:03.597719
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,preprints,Trans-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation,,2020,10.1101/2020.09.22.20198937,https://experts.mcmaster.ca/display/publication3234418,2025-07-27T15:06:03.597720
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,preprints,Clinical benefits and adverse effects of genetically-elevated free testosterone levels: a Mendelian randomization analysis,,2019,10.1101/19005132,https://experts.mcmaster.ca/display/publication3239693,2025-07-27T15:06:03.597722
Hertzel Chaim Gerstein,gerstein@mcmaster.ca,preprints,Penetrance of polygenic obesity susceptibility loci across the body mass index distribution: an update on scaling effects,,2017,10.1101/225128,https://experts.mcmaster.ca/display/publication3234421,2025-07-27T15:06:03.597723
